https://curecurrent.com/trials/a-safety-tolerability-and-levodopa-pharmacokinetics-study-of-repeated-nd0612-in-parkinson-s-disease-patients-66002https://curecurrent.com/trials/protocol-of-the-packer-managing-fatigue-program-versus-standard-information-to-improve-energy-conservation-self-efficacy-66003https://curecurrent.com/trials/artificial-intelligence-assisted-mds-updrs-assessment-for-parkinson-s-disease-66004https://curecurrent.com/trials/apathy-in-parkinson-disease-tms-study-66005https://curecurrent.com/trials/gait-analysis-in-neurological-disease-66006https://curecurrent.com/trials/investigation-of-the-benefits-of-electrical-non-invasive-stimulation-on-cognitive-symptoms-in-parkinson-s-disease-66007https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-vutiglabridin-in-early-parkinson-s-disease-patients-66008https://curecurrent.com/trials/pet-mri-of-reward-system-in-parkinson-s-disease-with-rbd-66009https://curecurrent.com/trials/cohort-study-to-identify-predictor-factors-of-onset-and-progression-of-parkinson-s-disease-66010https://curecurrent.com/trials/technology-assisted-nudging-to-increase-physical-activity-among-hospitalised-medical-patients-66011https://curecurrent.com/trials/vibrotactile-stimulation-for-parkinson-s-disease-66012https://curecurrent.com/trials/mobile-application-for-gait-training-in-parkinson-s-disease-66013https://curecurrent.com/trials/the-effects-of-tele-rehabilitation-based-dual-task-upper-extremity-training-in-patients-with-parkinson-s-disease-66014https://curecurrent.com/trials/optimizing-deep-brain-stimulation-to-improve-visuomotor-function-in-parkinson-s-disease-66015https://curecurrent.com/trials/subthalamic-nucleus-akinesia-and-parkinson-s-disease-66016https://curecurrent.com/trials/epidural-electrical-stimulation-to-support-hemodynamic-management-in-individuals-with-parkinson-s-disease-66017https://curecurrent.com/trials/remote-dynamic-cycling-for-the-customized-off-site-rehab-in-parkinson-s-disease-66018https://curecurrent.com/trials/l-theanine-and-mediterranean-diet-on-rbd-gi-function-and-inflammation-in-parkinson-s-disease-66019https://curecurrent.com/trials/aquatic-high-intensity-interval-training-for-parkinson-s-disease-66020https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-safety-tolerability-and-efficacy-of-intracerebral-injection-of-ly-n001-injection-for-th-66021https://curecurrent.com/trials/proprioceptive-exercise-in-parkinson-s-disease-66022https://curecurrent.com/trials/safety-and-tolerability-of-patterned-stimulation-for-dbs-in-the-home-setting-66023https://curecurrent.com/trials/sonification-techniques-for-gait-training-66024https://curecurrent.com/trials/evaluation-of-co-formulated-pembrolizumab-quavonlimab-mk-1308a-versus-other-treatments-in-participants-with-microsatelli-66025https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-energi-f705-tablets-for-parkinson-s-disease-66026https://curecurrent.com/trials/pathways-mediating-impaired-postural-control-in-parkinson-s-disease-66027https://curecurrent.com/trials/support-for-physical-activity-in-everyday-life-with-parkinson-s-disease-66028https://curecurrent.com/trials/the-effect-of-bottle-pep-exercise-on-expiratory-muscle-thickness-strength-and-balance-parameters-in-parkinson-s-disease-66029https://curecurrent.com/trials/probing-gut-brain-communication-in-parkinson-s-disease-66030https://curecurrent.com/trials/safety-and-efficacy-of-autologous-insc-dap-in-the-treatment-of-parkinson-s-disease-66031https://curecurrent.com/trials/enhancing-gait-using-alternating-frequency-dbs-in-parkinson-disease-66032https://curecurrent.com/trials/a-long-term-follow-up-study-of-the-severe-parkinson-s-disease-patients-administered-the-ips101a-gene-therapy-product-66033https://curecurrent.com/trials/the-efficacy-and-safety-of-transcutaneous-auricular-vagus-nerve-stimulation-for-depression-in-pd-66034https://curecurrent.com/trials/validation-of-a-novel-functional-food-designed-to-meet-the-nutritional-needs-of-people-living-with-parkinson-s-disease-66035https://curecurrent.com/trials/integrated-digital-and-neurogenic-exosome-biomarkers-for-early-diagnosis-of-parkinson-s-disease-development-and-applicat-66036https://curecurrent.com/trials/18f-mfbg-cardiac-uptake-with-lewy-body-dementia-66037https://curecurrent.com/trials/testing-of-an-interface-for-synchronizing-tacs-dbs-with-a-phase-locked-loop-66038https://curecurrent.com/trials/validation-of-cuestim-for-reduction-of-freezing-of-gait-in-parkinson-s-disease-66039https://curecurrent.com/trials/group-drum-based-music-therapy-intervention-for-parkinson-s-disease-huntington-s-disease-66040https://curecurrent.com/trials/outlining-biological-effects-of-subthalamic-deep-brain-stimulation-in-parkinson-s-disease-patients-66041https://curecurrent.com/trials/exercise-for-cognitive-excellence-in-parkinson-s-disease-66042https://curecurrent.com/trials/individualized-transcranial-magnetic-stimulation-in-parkinsonian-disorders-66043https://curecurrent.com/trials/effects-of-osteopathic-manipulative-treatment-protocol-on-sleep-quality-in-parkinson-s-disease-subjects-66044https://curecurrent.com/trials/virtual-reality-verses-conventional-physical-therapy-in-parkinson-s-disease-patients-66045https://curecurrent.com/trials/rtms-and-olfactory-training-for-parkinson-s-disease-66046https://curecurrent.com/trials/sustained-release-oral-formulation-for-treatment-of-parkinson-s-disease-66047https://curecurrent.com/trials/trial-of-parkinson-s-and-zoledronic-acid-66048https://curecurrent.com/trials/targeted-motor-learning-to-improve-gait-for-individuals-with-parkinson-disease-66049https://curecurrent.com/trials/impact-360-for-parkinson-s-disease-66050https://curecurrent.com/trials/cognitive-based-balance-rehabilitation-in-parkinson-s-disease-virtual-reality-vs-dual-task-66051https://curecurrent.com/trials/safety-and-initial-effectiveness-of-transcranial-mr-guided-focused-ultrasound-for-the-treatment-of-parkinson-s-disease-66052https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-safety-of-mf1-a-new-treatment-for-parkinson-s-disease-related-disorders-mf1-study-66053https://curecurrent.com/trials/temporal-interference-stimulation-on-motor-symptoms-in-parkinson-s-disease-66054https://curecurrent.com/trials/research-of-biomarkers-in-parkinson-disease-66055https://curecurrent.com/trials/subthalamic-nucleus-stimulation-with-directional-leads-on-patients-with-parkinson-disease-at-fluctuations-and-dyskinesia-66056https://curecurrent.com/trials/differential-diagnosis-between-parkinson-s-disease-and-multiple-system-atrophy-using-digital-speech-analysis-part-2-66057https://curecurrent.com/trials/boost-pd-a-naturalistic-study-on-ipx-203-for-parkinson-s-disease-66058https://curecurrent.com/trials/comparison-of-immersive-and-non-immersive-virtual-reality-rehabilitation-in-parkinson-s-disease-66059https://curecurrent.com/trials/effects-of-telerehabilitation-based-motor-and-cognitive-dual-task-exercise-in-patients-with-parkinson-s-disease-66060https://curecurrent.com/trials/adaptive-dbs-for-pd-66061https://curecurrent.com/trials/optimizing-protein-patterns-for-skeletal-muscle-preservation-and-sleep-in-the-medical-management-of-parkinson-disease-66062https://curecurrent.com/trials/a-clinical-trial-of-cap-003-gene-therapy-in-adult-patients-with-gba1-associated-parkinson-s-disease-66063https://curecurrent.com/trials/trial-of-four-spinal-cord-stimulation-paradigms-for-gait-impairment-in-parkinson-s-disease-66064https://curecurrent.com/trials/using-tavns-to-modulate-cardiovascular-function-in-individuals-with-neurologic-disease-66065https://curecurrent.com/trials/comparison-of-two-different-dual-task-training-methods-in-patients-with-parkinson-s-disease-66066https://curecurrent.com/trials/safety-and-feasibility-of-bilateral-striatal-transplantation-of-dopacell-in-parkinson-s-disease-66067https://curecurrent.com/trials/feasibility-of-an-adapted-mindfulness-program-to-parkinson-s-disease-66068https://curecurrent.com/trials/immediate-effects-of-external-trigeminal-nerve-stimulation-on-motor-dysfunction-in-parkinson-s-disease-66069https://curecurrent.com/trials/biomarkers-in-parkinsonian-syndromes-66070https://curecurrent.com/trials/validity-and-reliability-of-the-six-minute-pegboard-ring-test-in-individuals-with-parkinson-s-disease-66071https://curecurrent.com/trials/hf-rtms-primed-balance-training-on-corticomotor-excitability-balance-and-gait-in-parkinson-s-66072https://curecurrent.com/trials/conventional-physical-therapy-action-observation-therapy-on-freezing-of-gait-and-functional-mobility-in-parkinson-s-dise-66073https://curecurrent.com/trials/a-trial-to-test-the-use-of-dapansutrile-an-anti-inflammatory-medication-in-people-with-parkinson-s-disease-66074https://curecurrent.com/trials/apomorphine-pump-in-early-stage-of-parkinson-s-disease-early-pump-66075https://curecurrent.com/trials/radiation-therapy-rt-for-parkinson-s-disease-pd-66076https://curecurrent.com/trials/repurposing-lithium-for-parkinson-s-disease-a-rct-66077https://curecurrent.com/trials/nutritional-intervention-for-constipation-symptoms-in-patients-with-parkinson-s-disease-66078https://curecurrent.com/trials/sleep-quality-cognition-and-disease-severity-in-parkinson-s-disease-66079https://curecurrent.com/trials/full-spectrum-cannabidiol-oil-for-anxiety-and-depressive-symptoms-in-parkinson-s-disease-66080https://curecurrent.com/trials/effects-of-accelerated-rtms-on-motor-and-cognitive-function-in-parkinson-s-disease-66081https://curecurrent.com/trials/at-home-tavns-for-neurorehabilitation-in-parkinson-s-disease-66082https://curecurrent.com/trials/rhythm-psychophysics-with-parkinson-s-patients-66083https://curecurrent.com/trials/a-first-in-human-dose-escalation-and-indication-expansion-study-of-bnt3212-as-monotherapy-or-in-combination-with-bnt327-66084https://curecurrent.com/trials/electrophysiological-activity-of-the-subthalamic-nucleus-during-the-processing-of-emotional-and-motivational-information-66085https://curecurrent.com/trials/pilot-study-of-the-felix-system-in-patients-with-essential-tremor-and-parkinson-s-tremor-66086https://curecurrent.com/trials/corticostriatal-contributions-to-parkinson-s-disease-cognitive-impairment-66087https://curecurrent.com/trials/efficacy-of-a-prediction-model-based-algorithm-to-prevent-drug-induced-impulse-control-disorders-in-parkinson-s-disease-66088https://curecurrent.com/trials/impact-of-nilotinib-on-safety-tolerability-pharmacokinetics-and-biomarkers-in-parkinson-s-disease-66089https://curecurrent.com/trials/study-of-the-efficacy-of-n-acetylcysteine-nac-on-impulse-control-disorders-66090https://curecurrent.com/trials/neurophysiology-of-reward-signaling-in-parkinson-s-disease-66091https://curecurrent.com/trials/prospective-multicenter-registry-study-of-multiple-system-atrophy-in-china-66092https://curecurrent.com/trials/evaluation-of-clinical-perfectionism-in-parkinson-disease-66093https://curecurrent.com/trials/striatal-and-extra-striatal-cholinergic-terminal-density-in-lrrk2-pd-mutation-66094https://curecurrent.com/trials/effects-of-lemborexant-on-motor-sleep-comorbidity-in-parkinson-s-disease-66095https://curecurrent.com/trials/the-motor-network-in-parkinson-s-disease-and-dystonia-mechanisms-of-therapy-66096https://curecurrent.com/trials/an-exploratory-clinical-study-of-ux-da001-in-subjects-with-idiopathic-parkinson-s-disease-66097https://curecurrent.com/trials/telerehabilitation-versus-face-to-face-lsvt-big-in-individuals-with-parkinson-disease-66098https://curecurrent.com/trials/effect-of-training-and-use-of-cane-on-gait-in-individuals-with-parkinson-s-disease-66099https://curecurrent.com/trials/natural-history-study-of-synucleinopathies-66100https://curecurrent.com/trials/evaluation-of-f-modag-009-pet-imaging-in-synucleinopathies-66101https://curecurrent.com/trials/characterization-of-the-involvement-of-the-subthalamic-nucleus-during-wakefulness-and-sleep-in-parkinson-s-disease-contr-66102https://curecurrent.com/trials/effects-of-targeted-temporal-interference-stimulation-of-cerebellar-nuclei-on-tremor-and-gait-disturbance-in-parkinson-s-66103https://curecurrent.com/trials/clinical-trial-for-parkinson-s-disease-using-allogeneic-hb-admscs-early-and-moderate-pd-66104https://curecurrent.com/trials/evaluation-of-a-soft-elbow-exoskeleton-and-a-haptic-armband-in-post-stroke-and-parkinson-s-disease-patients-66105https://curecurrent.com/trials/depression-anxiety-and-sleep-in-parkinson-s-disease-66106https://curecurrent.com/trials/sensing-in-sleep-deep-brain-stimulation-66107https://curecurrent.com/trials/auto-calibrating-system-for-upper-limb-disability-assessment-neurological-and-occupational-rehabilitation-66108https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-hrg2010-in-parkinson-s-disease-with-motor-fluctuations-66109https://curecurrent.com/trials/brain-networks-and-consciousness-66110https://curecurrent.com/trials/local-field-potential-correlates-of-neuropsychiatric-symptoms-in-parkinson-s-disease-66111https://curecurrent.com/trials/remote-haptic-rehabilitation-for-parkinson-s-disease-66112https://curecurrent.com/trials/sad-study-in-patients-with-parkinson-s-disease-and-motor-fluctuations-66113https://curecurrent.com/trials/a-study-to-evaluate-the-bioavailability-of-pembrolizumab-mk-3475-via-subcutaneous-sc-injection-of-pembrolizumab-formulat-66114https://curecurrent.com/trials/understanding-motivation-in-parkinson-s-patients-through-neurophysiology-66115https://curecurrent.com/trials/a-study-to-learn-about-the-safety-of-biib122-tablets-and-whether-they-can-slow-the-worsening-of-early-stage-parkinson-s-66116https://curecurrent.com/trials/study-on-preliminary-safety-and-efficacy-of-the-arc-im-therapy-to-alleviate-locomotor-deficits-in-people-with-parkinson-66117https://curecurrent.com/trials/the-meals-study-for-amyotrophic-lateral-sclerosis-and-parkinson-s-disease-66118https://curecurrent.com/trials/subthalamic-nucleus-targeted-transcranial-temporal-interference-stimulation-for-motor-and-non-motor-symptoms-in-parkinso-66119https://curecurrent.com/trials/pilot-deprescribing-of-antimuscarinic-overactive-bladder-medications-in-parkinson-disease-66120https://curecurrent.com/trials/d-spark-a-clinical-trial-of-d-serine-for-modifying-parkinson-s-disease-progression-66121https://curecurrent.com/trials/behavioral-intervention-for-lifestyle-physical-activity-in-parkinson-s-disease-66122https://curecurrent.com/trials/blood-flow-restriction-and-exercise-in-parkinson-s-disease-66123https://curecurrent.com/trials/evaluation-of-the-pharmacokinetics-biodistribution-and-radiation-dosimetry-of-18f-modag-009-positron-emission-tomography-66124https://curecurrent.com/trials/subthalamic-steering-for-therapy-optimization-in-parkinson-s-disease-66125https://curecurrent.com/trials/dysarthria-management-for-minor-groups-66126https://curecurrent.com/trials/occupational-therapy-led-social-prescription-for-people-with-parkinson-disease-66127https://curecurrent.com/trials/biomechanical-effects-of-emst-on-swallowing-function-in-parkinson-s-disease-66128https://curecurrent.com/trials/effects-of-dual-task-training-on-upper-extremity-function-in-parkinson-s-disease-66129https://curecurrent.com/trials/mindfulness-meditation-mbsr-and-parkinson-s-disease-pd-66130https://curecurrent.com/trials/developing-precision-microbiota-based-cocktail-modification-therapy-to-delay-the-progression-of-parkinson-s-disease-pd-u-66131https://curecurrent.com/trials/relative-bioavailability-study-of-hnc364-injectable-suspension-66132https://curecurrent.com/trials/study-to-assess-adverse-events-and-change-in-disease-activity-of-24-hour-continuous-subcutaneous-infusion-of-abbv-951-in-66133https://curecurrent.com/trials/study-on-feasibility-of-targeted-epidural-spinal-stimulation-tess-to-improve-mobility-in-patients-with-parkinson-s-disea-66134https://curecurrent.com/trials/wearable-assessments-in-the-clinic-and-home-in-pd-66135https://curecurrent.com/trials/dyadic-mindfulness-for-people-with-parkinson-s-disease-and-their-caregivers-66136https://curecurrent.com/trials/results-of-combined-medical-and-swallowing-behavioral-readjustment-therapy-in-oropharyngeal-dysphagia-management-among-p-66137https://curecurrent.com/trials/imaging-core-aim-2-and-udall-project-2-aim-2-66138https://curecurrent.com/trials/evaluation-of-the-impact-of-virtual-park-on-training-motivation-in-adult-patients-66139https://curecurrent.com/trials/cognitive-decline-following-deep-brain-stimulation-66140https://curecurrent.com/trials/continuous-wearable-monitor-for-the-detection-and-release-of-freezing-of-gait-66141https://curecurrent.com/trials/exercise-strategies-in-parkinson-s-disease-66142https://curecurrent.com/trials/dual-tasking-training-to-enhance-self-efficacy-in-individuals-with-parkinson-s-disease-66143https://curecurrent.com/trials/use-of-ceregate-therapy-for-freezing-of-gait-in-pd-66144https://curecurrent.com/trials/early-molecular-biomarkers-for-differentiating-parkinsonian-syndromes-66145https://curecurrent.com/trials/clinical-trail-of-transcranial-mr-guided-focused-ultrasound-in-the-treatment-of-motor-symptoms-in-patients-with-parkinso-66146https://curecurrent.com/trials/trunk-control-exercises-and-mirror-therapy-on-balance-and-posture-in-parkinson-s-disease-66147https://curecurrent.com/trials/intestinal-immunity-in-neurologic-disease-66148https://curecurrent.com/trials/smart-wearable-device-gaitq-walk-better-project-66149https://curecurrent.com/trials/safety-and-pharmacodynamic-effects-of-biib122-in-participants-with-lrrk2-associated-parkinson-s-disease-lrrk2-pd-66150https://curecurrent.com/trials/can-subthalamic-stimulation-using-directional-electrodes-improve-postoperative-management-in-parkinson-s-disease-66151https://curecurrent.com/trials/zesty-exercise-system-for-therapeutic-engagement-66152https://curecurrent.com/trials/a-study-of-coformulated-favezelimab-pembrolizumab-mk-4280a-versus-standard-of-care-in-subjects-with-previously-treated-m-66153https://curecurrent.com/trials/effects-of-home-based-high-speed-bodyweight-resistance-training-in-individual-with-parkinson-s-disease-66154https://curecurrent.com/trials/speech-as-biomarker-for-emotion-movement-and-cognition-in-parkinson-s-disease-66155https://curecurrent.com/trials/acceptability-of-the-somnomat-casa-for-the-treatment-of-parkinson-s-disease-66156https://curecurrent.com/trials/pembrolizumab-mk-3475-plus-epacadostat-vs-standard-of-care-in-mrcc-keynote-679-echo-302-66157https://curecurrent.com/trials/evaluation-of-long-term-safety-in-parkinsonian-patients-with-intracerebroventricular-administration-of-a-dopamine-anaero-66158https://curecurrent.com/trials/balance-tele-rehab-in-parkinson-s-disease-66159https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-versus-chemotherapy-in-chinese-participants-with-stage-iv-colorectal-cancer-mk-3475-c66-66160https://curecurrent.com/trials/parkinson-s-disease-biomarkers-in-nerve-cells-in-the-gut-66161https://curecurrent.com/trials/the-effect-of-alcohol-on-common-tremor-syndromes-66162https://curecurrent.com/trials/speech-amplification-devices-for-parkinson-disease-talker-and-technology-driven-enhancements-66163https://curecurrent.com/trials/smartphone-based-wearable-telerehabilitation-66164https://curecurrent.com/trials/exergaming-for-improving-upper-limb-functions-in-parkinson-s-disease-66165https://curecurrent.com/trials/fecal-microbiota-transplantation-in-parkinson-s-disease-66166https://curecurrent.com/trials/parkinson-brasil-database-on-motor-and-non-motor-aspects-of-parkinson-s-disease-in-brazil-66167https://curecurrent.com/trials/aquaporin-4-single-nucleotide-polymorphisms-in-patients-with-idiopathic-and-familial-parkinson-s-disease-66168https://curecurrent.com/trials/a-study-of-belzutifan-mk-6482-plus-pembrolizumab-mk-3475-versus-placebo-plus-pembrolizumab-in-participants-with-clear-ce-66169https://curecurrent.com/trials/robot-assisted-gait-training-vs-nmes-in-parkinson-s-disease-66170https://curecurrent.com/trials/adapting-rhire-and-sleep-monitoring-in-parkinson-s-disease-66171https://curecurrent.com/trials/physical-activity-in-persons-with-parkinson-s-disease-66172https://curecurrent.com/trials/an-observational-study-of-subcutaneous-infusion-of-abbv-951-to-assess-change-in-disease-activity-and-adverse-events-in-a-66173https://curecurrent.com/trials/a-multimodal-convergent-cohort-of-parkinson-s-disease-at-fjmuuh-fjmuuh-pd-natural-history-study-66174https://curecurrent.com/trials/phase-1-2a-study-of-anpd001-in-parkinson-disease-66175https://curecurrent.com/trials/study-of-methylphenidate-to-treat-gait-disorders-and-attention-deficit-in-parkinson-s-disease-parkgait-ii-66176https://curecurrent.com/trials/rhythmic-auditory-stimulation-on-upper-limb-movements-in-pd-patients-66177https://curecurrent.com/trials/efficacy-and-safety-of-the-iron-chelator-deferiprone-in-parkinson-s-disease-66178https://curecurrent.com/trials/cognitive-phenotypes-in-parkinson-s-disease-66179https://curecurrent.com/trials/study-of-memantine-for-gait-disorders-and-attention-deficit-in-parkinson-s-disease-66180https://curecurrent.com/trials/motor-and-cognitive-telerehabilitation-in-a-virtual-environment-in-patients-with-post-stroke-sequelae-and-parkinson-s-di-66181https://curecurrent.com/trials/dopaminergic-restauration-by-intraventriculaire-administration-66182https://curecurrent.com/trials/oxidative-stress-and-apoptosis-of-energy-metabolism-by-deferiprone-from-the-circulating-lymphocytes-66183https://curecurrent.com/trials/weight-changes-in-parkinsonian-patients-treated-with-deep-brain-stimulation-66184https://curecurrent.com/trials/exoskeleton-assisted-mobility-in-aging-and-in-parkinson-s-disease-66185https://curecurrent.com/trials/efficacy-safety-tolerability-pharmacodynamics-and-pharmacokinetics-of-bia-28-6156-in-gba-pd-66186https://curecurrent.com/trials/retraining-gait-in-parkinson-s-disease-via-a-personalised-app-66187https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-monosialotetrahexosylganglioside-sodium-injection-in-parkinson-s-disease-66188https://curecurrent.com/trials/extension-study-to-evaluate-safety-and-tolerability-of-24-hour-daily-exposure-of-continuous-subcutaneous-infusion-of-abb-66189https://curecurrent.com/trials/real-world-study-of-foslevodopa-foscarbidopa-to-assess-quality-of-life-outcomes-in-adult-participants-with-advanced-park-66190https://curecurrent.com/trials/north-american-prodromal-synucleinopathy-consortium-stage-2-66191https://curecurrent.com/trials/repurposing-lithium-for-parkinson-s-disease-66192https://curecurrent.com/trials/emg-of-gait-under-dual-task-in-parkinson-desease-66193https://curecurrent.com/trials/aid-fog-artificial-intelligence-driven-freezing-of-gait-detection-in-the-home-66194https://curecurrent.com/trials/c-star-movement-database-66195https://curecurrent.com/trials/personality-and-quality-of-life-amelioration-after-continuous-subcutaneous-apomorphine-infusion-in-parkinson-s-disease-66196https://curecurrent.com/trials/new-clinical-rehabilitation-approach-for-the-management-of-falls-risks-66197https://curecurrent.com/trials/pet-imaging-in-parkinson-disease-dementia-66198https://curecurrent.com/trials/this-clinical-trial-is-designed-to-evaluate-the-safety-tolerability-feasibility-and-preliminary-efficacy-of-nouvneu001-h-66199https://curecurrent.com/trials/patient-specific-3d-action-observation-training-in-parkinson-s-disease-66200https://curecurrent.com/trials/pain-in-parkinson-s-disease-exploration-of-the-serotonin-system-in-positron-emission-tomography-pet-18f-mppf-66201https://curecurrent.com/trials/prevention-of-medical-social-and-psychosocial-risks-following-a-parkinson-s-disease-diagnosis-a-pilot-study-66202https://curecurrent.com/trials/psilocybin-therapy-for-psychological-distress-in-palliative-patients-66203https://curecurrent.com/trials/investigations-of-dementia-in-parkinson-disease-66204https://curecurrent.com/trials/impact-of-force-control-of-hip-abductor-muscles-in-healthy-adults-and-individuals-with-parkinson-s-disease-66205https://curecurrent.com/trials/safety-and-feasibility-of-tele-supervised-home-based-transcranial-direct-current-stimulation-in-parkinson-s-disease-66206https://curecurrent.com/trials/probiotic-treatment-for-depression-and-associated-mood-disorders-in-parkinson-s-disease-66207https://curecurrent.com/trials/changes-in-movement-fitness-and-quality-of-life-in-people-with-parkinson-s-disease-after-different-exercise-programs-66208https://curecurrent.com/trials/aim-3-particle-swarm-optimization-pigd-66209https://curecurrent.com/trials/smartshoes-for-freezing-of-gait-in-parkinson-s-disease-66210https://curecurrent.com/trials/multiple-objective-particle-swarm-optimization-postural-instability-gait-disorder-66211https://curecurrent.com/trials/feasibility-of-objective-measures-and-outpatient-washout-in-disease-modifying-trials-for-parkinson-s-disease-66212https://curecurrent.com/trials/o-arm-stereotactic-imaging-in-deep-brain-stimulation-for-parkinson-s-disease-66213https://curecurrent.com/trials/closed-loop-tms-for-tremor-66214https://curecurrent.com/trials/pathophysiology-of-neuronal-oscillations-within-subthalamo-cortical-loops-in-parkinson-s-disease-66215https://curecurrent.com/trials/therapeutic-education-in-parkinson-s-disease-what-impact-on-drug-representations-of-patients-etpark-remed-66216https://curecurrent.com/trials/effects-of-ras-on-gait-in-pd-patients-with-dbs-66217https://curecurrent.com/trials/functional-neuroimaging-in-parkinson-s-disease-66218https://curecurrent.com/trials/combined-deep-brain-stimulation-in-parkinson-s-disease-66219https://curecurrent.com/trials/exenatide-once-weekly-over-2-years-as-a-potential-disease-modifying-treatment-for-parkinson-s-disease-66220https://curecurrent.com/trials/a-prospective-randomized-controlled-trial-to-test-safety-and-effectiveness-of-unilateral-exablate-mr-guided-focused-ultr-66221https://curecurrent.com/trials/reliability-and-validity-of-sensor-derived-measurements-in-individuals-with-parkinson-s-disease-preliminary-results-from-66222https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-versus-chemotherapy-in-mismatch-repair-deficient-dmmr-advanced-or-recurrent-endometrial-c-66223https://curecurrent.com/trials/attention-and-eye-movement-in-parkinson-s-disease-66224https://curecurrent.com/trials/effects-of-pr-oxycodone-and-of-levodopa-vs-placebo-on-central-neuropathic-pain-in-parkinson-s-disease-66225https://curecurrent.com/trials/visual-characterization-of-parkinson-s-patients-and-oculomotor-or-perceptual-therapy-66226https://curecurrent.com/trials/enrichment-of-glutathione-using-gamma-glutamylcysteine-supplementation-in-parkinson-s-disease-patients-66227https://curecurrent.com/trials/robotic-gait-rehabilitation-in-parkinson-s-disease-66228https://curecurrent.com/trials/understanding-alpha-synuclein-spread-in-parkinson-s-disease-through-blood-biomarkers-and-neuroimaging-66229https://curecurrent.com/trials/a-trial-to-evaluate-safety-and-efficacy-of-a-product-named-vgn-r08b-in-parkinson-s-disease-patients-with-gba1-mutations-66230https://curecurrent.com/trials/acute-effects-of-amps-on-cardiovascular-functional-capacity-and-postural-control-in-patients-with-parkinson-s-disease-66231https://curecurrent.com/trials/tdcs-on-parkinson-s-disease-cognition-66232https://curecurrent.com/trials/adaptive-deep-brain-stimulation-to-improve-motor-and-gait-functions-in-parkinson-s-disease-66233https://curecurrent.com/trials/pain-assessment-in-patients-with-idiopathic-rapid-eye-movement-rem-sleep-behaviour-disorder-66234https://curecurrent.com/trials/evaluation-of-neuroinflammation-in-parkinson-s-disease-using-18f-nos-pet-ct-66235https://curecurrent.com/trials/direct-measurement-of-motor-cortical-responses-to-tdcs-66236https://curecurrent.com/trials/efficacy-and-safety-of-pembrolizumab-mk-3475-in-combination-with-bacillus-calmette-guerin-bcg-in-high-risk-non-muscle-in-66237https://curecurrent.com/trials/using-low-intensity-focused-ultrasound-to-modulate-deep-brain-areas-for-tremor-control-in-parkinson-s-disease-patients-66238https://curecurrent.com/trials/auditory-sleep-stimulation-or-sham-in-people-with-parkinson-disease-mild-cognitive-impairment-during-cognitive-training-66239https://curecurrent.com/trials/education-for-adapted-physical-activity-in-parkinson-s-disease-66240https://curecurrent.com/trials/effect-of-kinesiotaping-on-tremor-in-people-with-parkinson-s-disease-66241https://curecurrent.com/trials/mental-health-support-for-people-affected-by-parkinson-s-66242https://curecurrent.com/trials/cuepd-investigating-the-effect-of-personalised-auditory-cueing-on-gait-in-parkinson-s-disease-66243https://curecurrent.com/trials/impact-of-diet-on-the-microbiome-immune-brain-axis-in-parkinson-s-disease-66244https://curecurrent.com/trials/movement-state-dependent-adaptive-dbs-for-pd-66245https://curecurrent.com/trials/adaptive-deep-brain-stimulation-for-freezing-of-gait-in-parkinson-s-disease-66246https://curecurrent.com/trials/the-effect-of-long-term-daily-stimulation-of-the-brain-with-pulsed-electromagnetic-fields-on-parkinsons-disease-66247https://curecurrent.com/trials/world-data-on-ambroxol-for-patients-with-gd-and-gba-related-pd-66248https://curecurrent.com/trials/brain-training-to-improve-balance-in-parkinson-s-disease-66249https://curecurrent.com/trials/efficacy-and-safety-of-lenvatinib-e7080-mk-7902-plus-pembrolizumab-mk-3475-plus-chemotherapy-in-participants-with-advanc-66250https://curecurrent.com/trials/effectiveness-of-virtual-reality-in-parkinson-s-disease-effects-on-balance-fall-risk-and-exercise-capacity-66251https://curecurrent.com/trials/personalized-rtms-protocol-based-on-functional-reserve-to-enhance-ambulatory-function-in-pd-patients-66252https://curecurrent.com/trials/stress-management-and-resiliency-training-program-for-parkinson-s-disease-66253https://curecurrent.com/trials/effects-of-exercise-training-and-ketone-ester-on-muscle-strength-and-cardiovascular-response-in-parkinson-s-disease-66254https://curecurrent.com/trials/self-administered-tdcs-for-improving-single-and-dual-task-gait-in-patients-with-pd-66255https://curecurrent.com/trials/automated-image-guided-programming-of-deep-brain-stimulation-dbs-for-parkinson-s-disease-66256https://curecurrent.com/trials/effects-of-an-independent-walking-program-with-walking-poles-in-people-with-parkinson-disease-66257https://curecurrent.com/trials/real-world-study-of-abbv-951-subcutaneous-infusion-to-assess-change-in-disease-activity-in-adult-participants-with-parki-66258https://curecurrent.com/trials/effects-of-blood-pressure-on-cognition-and-cerebral-hemodynamics-in-pd-66259https://curecurrent.com/trials/safety-and-efficacy-of-pembrolizumab-mk-3475-versus-placebo-as-adjuvant-therapy-in-participants-with-hepatocellular-carc-66260https://curecurrent.com/trials/study-of-biodistribution-metabolism-excretion-and-brain-uptake11c-m503-66261https://curecurrent.com/trials/vibrotactile-coordinated-reset-a-non-invasive-treatment-for-parkinson-s-disease-2-66262https://curecurrent.com/trials/phase-i-clinical-study-of-nouvneu001-injection-for-the-treatment-of-moderate-to-advanced-parkinson-s-disease-in-patients-66263https://curecurrent.com/trials/open-label-single-arm-prebiotic-pilot-trial-sr001-66264https://curecurrent.com/trials/clinical-study-of-chemogenetic-gene-therapy-with-aav-for-parkinson-s-disease-using-stereotactic-surgery-in-the-subthalam-66265https://curecurrent.com/trials/patterned-multichannel-vibrotactile-stimulation-for-the-longitudinal-treatment-of-moderate-stage-parkinson-s-disease-66266https://curecurrent.com/trials/periodization-and-parkinson-s-disease-66267https://curecurrent.com/trials/study-of-axial-and-cognitive-symptoms-and-biomarkers-of-neurodegeneration-in-brain-first-and-body-first-pd-66268https://curecurrent.com/trials/listener-training-for-improved-intelligibility-of-people-with-parkinson-s-disease-66269https://curecurrent.com/trials/cerebellar-transcranial-direct-current-stimulation-in-parkinson-s-disease-66270https://curecurrent.com/trials/a-phase-2a-multicenter-clinical-trial-of-tb006-in-participants-with-parkinson-s-disease-66271https://curecurrent.com/trials/short-and-long-term-responses-of-pd-symptoms-to-earstim-66272https://curecurrent.com/trials/intrapatient-comparison-of-stn-and-gpi-ttis-in-pd-66273https://curecurrent.com/trials/safety-evaluation-of-intravenous-talineuren-tln-in-parkinson-s-disease-affected-patients-66274https://curecurrent.com/trials/predictive-factors-and-subthalamic-stimulation-in-parkinson-s-disease-66275https://curecurrent.com/trials/rtms-to-improve-cognition-in-parkinson-s-66276https://curecurrent.com/trials/phase-1-clinical-trial-to-evaluate-the-safety-efficacy-and-pharmacokinetics-of-ips101a-in-parkinson-s-disease-patients-66277https://curecurrent.com/trials/efficacy-and-safety-study-of-myobloc-in-the-treatment-of-sialorrhea-in-adult-subjects-66278https://curecurrent.com/trials/evaluation-of-correlation-between-oculometric-measures-and-clinical-assessment-in-parkinson-s-disease-66279https://curecurrent.com/trials/a-system-to-help-with-freezing-of-gait-in-parkinson-s-patients-66280https://curecurrent.com/trials/a-multi-center-study-of-myobloc-for-the-treatment-of-sialorrhea-in-parkinson-s-disease-patients-66281https://curecurrent.com/trials/remote-therapeutic-monitoring-exercise-tracking-66282https://curecurrent.com/trials/effects-of-cognitive-dual-task-on-gait-in-parkinson-s-disease-66283https://curecurrent.com/trials/a-study-of-ly4006896-in-healthy-participants-and-participants-with-parkinson-s-disease-66284https://curecurrent.com/trials/rtms-over-the-dorsolateral-prefrontal-cortex-for-the-treatment-of-impulse-control-disorders-in-parkinson-s-disease-66285https://curecurrent.com/trials/to-evaluate-the-efficacy-of-cvn424-in-parkinson-s-disease-participants-with-motor-complications-66286https://curecurrent.com/trials/pain-and-autonomic-symptoms-in-parkinson-s-disease-and-atypical-parkinsonisms-66287https://curecurrent.com/trials/first-in-human-single-and-multiple-dose-of-hl-400-66288https://curecurrent.com/trials/the-swedish-biofinder-sleep-study-66289https://curecurrent.com/trials/collaborative-vs-non-immersive-vr-in-parkinson-s-rehabilitation-66290https://curecurrent.com/trials/pembrolizumab-mk-3475-plus-gemcitabine-cisplatin-versus-placebo-plus-gemcitabine-cisplatin-for-first-line-advanced-and-o-66291https://curecurrent.com/trials/resistant-maltodextrin-for-gut-microbiome-in-parkinson-s-disease-safety-and-tolerability-study-66292https://curecurrent.com/trials/home-based-self-exercise-in-patients-with-parkinson-s-disease-a-feasibility-study-66293https://curecurrent.com/trials/randomized-double-blind-clinical-trial-for-parkinson-s-disease-early-and-moderate-66294https://curecurrent.com/trials/phase-2a-study-of-vtx3232-in-parkinson-s-disease-66295https://curecurrent.com/trials/ketamine-for-veterans-with-parkinson-s-disease-66296https://curecurrent.com/trials/brief-title-aerobic-training-on-cerebrovascular-function-cognition-and-gait-in-parkinson-s-disease-66297https://curecurrent.com/trials/rostock-international-parkinson-s-disease-study-ropad-66298https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-esc-derived-dopamine-progenitor-cell-therapy-in-pd-patients-66299https://curecurrent.com/trials/dance-and-energy-expenditure-among-adults-with-parkinson-s-66300https://curecurrent.com/trials/neuroimaging-of-parkinson-s-66301https://curecurrent.com/trials/genotypic-influences-on-network-progression-in-parkinson-s-disease-66302https://curecurrent.com/trials/effects-of-physical-exercise-combined-with-transcranial-direct-current-stimulation-in-parkinson-s-disease-66303https://curecurrent.com/trials/steady-together-fall-prevention-program-in-the-home-66304https://curecurrent.com/trials/effects-of-stimulation-patterns-of-deep-brain-stimulation-66305https://curecurrent.com/trials/quantitative-imaging-of-brain-glymphatic-function-in-humans-66306https://curecurrent.com/trials/vestibulopathy-as-a-cause-of-imbalance-in-parkinson-66307https://curecurrent.com/trials/bacillus-subtilis-in-parkinson-s-disease-66308https://curecurrent.com/trials/udall-project-1-aim-4-66309https://curecurrent.com/trials/etoricoxib-in-patients-with-parkinsonian-disease-66310https://curecurrent.com/trials/cpap-for-the-treatment-of-supine-hypertension-66311https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-safety-tolerability-and-pharmacokinetics-of-ucb0022-in-study-participants-with-advanced-66312https://curecurrent.com/trials/amantadine-and-l-dopa-induced-dyskinesia-in-early-parkinson-s-disease-66313https://curecurrent.com/trials/low-voltage-electrical-stimulation-for-depression-in-parkinson-s-patients-66314https://curecurrent.com/trials/sing-for-your-saunter-part-2-r33-66315https://curecurrent.com/trials/effects-of-resistance-and-aerobic-exercises-on-walking-and-sarcopenic-parameters-in-parkinson-s-disease-66316https://curecurrent.com/trials/cs1p1-pet-studies-of-neuroinflammation-in-parkinson-disease-66317https://curecurrent.com/trials/an-extension-study-to-evaluate-the-long-term-efficacy-safety-and-tolerability-of-minzasolmin-ucb0599-in-study-participan-66318https://curecurrent.com/trials/an-integrated-and-personalized-lifestyle-approach-for-people-with-parkinson-s-disease-66319https://curecurrent.com/trials/remote-neuropsychological-assessment-of-patients-with-neurological-disorders-and-injuries-66320https://curecurrent.com/trials/primary-parkinsonian-pain-diagnostic-questionnaire-development-and-validation-of-this-questionnaire-66321https://curecurrent.com/trials/upper-extremity-rehabilitation-with-virtual-reality-in-parkinson-s-disease-patients-66322https://curecurrent.com/trials/blood-flow-restriction-for-optimizing-balance-in-parkinson-s-disease-66323https://curecurrent.com/trials/exercise-management-in-parkinson-s-disease-66324https://curecurrent.com/trials/high-frequency-light-sound-and-tactile-stimulation-to-improve-motor-and-cognitive-deficits-in-parkinson-s-disease-66325https://curecurrent.com/trials/reducing-falls-with-varenicline-in-hypocholinergic-parkinson-disease-66326https://curecurrent.com/trials/enhancing-nursing-students-empathy-and-learning-in-parkinson-s-disease-through-high-fidelity-simulation-and-blended-lear-66327https://curecurrent.com/trials/a-trial-to-evaluate-safety-and-efficacy-of-a-product-named-vgn-r09b-in-patients-with-parkinson-s-disease-66328https://curecurrent.com/trials/effects-of-an-independent-walking-program-with-walking-poles-in-people-with-parkinson-disease-66329https://curecurrent.com/trials/clinical-efficacy-of-a-telerehabilitation-protocol-for-the-improvement-of-balance-in-degenerative-neurological-diseases-66330https://curecurrent.com/trials/electrophysiology-based-dbs-programming-for-pd-66331https://curecurrent.com/trials/implementing-a-national-biobank-of-pd-with-wgs-and-functional-assessment-of-polygenic-inheritance-by-ipsc-technology-66332https://curecurrent.com/trials/neurosurgical-outcome-network-66333https://curecurrent.com/trials/inhibitory-control-and-gait-adaptability-in-parkinson-s-disease-66334https://curecurrent.com/trials/the-effects-of-mindfulness-based-cognitive-therapy-in-people-with-parkinson-s-disease-66335https://curecurrent.com/trials/high-intensity-interval-circuit-training-in-people-with-parkinson-disease-66336https://curecurrent.com/trials/deep-neural-network-approaches-for-closed-loop-deep-brain-stimulation-66337https://curecurrent.com/trials/plasma-a-synuclein-aggregation-seeding-activity-as-a-novel-biomarker-for-neurodegeneration-disease-66338https://curecurrent.com/trials/multidimensional-assessment-of-fatigability-in-older-adults-living-in-southern-switzerland-and-elderly-with-parkinson-s-66339https://curecurrent.com/trials/thoracolumbar-fascia-thickness-in-patients-with-parkinson-s-disease-66340https://curecurrent.com/trials/observational-study-evaluating-robotic-spinal-mobilization-in-16-parkinson-s-disease-participants-the-study-recorded-cha-66341https://curecurrent.com/trials/severity-of-sarcopenia-in-parkinson-s-disease-66342https://curecurrent.com/trials/cortical-basal-ganglia-speech-networks-66343https://curecurrent.com/trials/treating-parkinson-s-disease-through-transplantation-of-autologous-stem-cell-derived-dopaminergic-neurons-66344https://curecurrent.com/trials/in-vivo-measurement-of-the-accuracy-of-the-neurolocate-module-of-the-neurosurgical-robot-neuromate-in-its-application-to-66345https://curecurrent.com/trials/context-and-terrain-aware-gait-analysis-66346https://curecurrent.com/trials/tis-for-brain-network-modulation-and-clinical-efficacy-in-parkinson-s-disease-66347https://curecurrent.com/trials/pembrolizumab-mk-3475-plus-gemcitabine-cisplatin-versus-placebo-plus-gemcitabine-cisplatin-for-first-line-advanced-and-o-66348https://curecurrent.com/trials/effects-of-amps-on-cardiovascular-and-functional-variables-in-patients-with-parkinson-s-disease-66349https://curecurrent.com/trials/brain-activity-cognitive-function-and-walking-ability-in-parkinson-s-disease-66350https://curecurrent.com/trials/respiratory-functions-in-parkinson-s-disease-66351https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-exablate-subthalomotomy-for-the-treatment-of-parkinson-s-disease-motor-fe-66352https://curecurrent.com/trials/targeting-apathy-with-music-in-parkinson-s-disease-66353https://curecurrent.com/trials/cue-x-as-a-treatment-for-people-with-parkinson-s-disease-66354https://curecurrent.com/trials/effects-of-the-stimulation-site-of-tsms-with-tms-on-functional-mobility-in-individuals-with-parkinson-s-disease-66355https://curecurrent.com/trials/microbiome-and-diet-in-parkinson-s-disease-66356https://curecurrent.com/trials/early-parkinson-s-disease-monotherapy-with-cvn424-66357https://curecurrent.com/trials/a-clinical-study-of-dihydroergotine-mesylate-extended-release-tablets-for-the-treatment-of-drooling-in-parkinson-s-disea-66358https://curecurrent.com/trials/interest-of-continuous-subcutaneous-apomorphine-in-parkinsonian-patients-at-the-end-of-life-66359https://curecurrent.com/trials/ketogenic-diet-interventions-in-parkinson-s-disease-safeguarding-the-gut-microbiome-66360https://curecurrent.com/trials/a-post-approval-registry-for-exablate-4000-type-1-0-and-type-1-1-for-unilateral-pallidotomy-for-the-treatment-of-advance-66361https://curecurrent.com/trials/effects-of-strategy-training-and-pnf-on-balance-gait-and-independence-in-parkinson-s-disease-66362https://curecurrent.com/trials/bright-light-therapy-for-non-motor-symptoms-in-parkinson-s-disease-66363https://curecurrent.com/trials/blood-brain-barrier-disruption-with-cerezyme-in-patient-s-with-parkinson-s-disease-66364https://curecurrent.com/trials/persevere-peer-mentor-support-and-caregiver-education-in-lewy-body-dementia-66365https://curecurrent.com/trials/a-post-approval-registry-for-exablate-4000-type-1-0-and-type-1-1-for-unilateral-thalamotomy-for-the-treatment-of-medicat-66366https://curecurrent.com/trials/a-study-to-evaluate-temporary-blood-brain-barrier-disruption-in-patients-with-parkinson-s-disease-dementia-66367https://curecurrent.com/trials/exablate-pallidotomy-for-medically-refractory-dyskinesia-symptoms-or-motor-fluctuations-of-advanced-parkinson-s-disease-66368https://curecurrent.com/trials/effectiveness-of-online-program-and-task-related-training-for-parkinson-s-disease-66369https://curecurrent.com/trials/research-into-the-safety-of-a-new-agent-vt-5006-in-people-with-and-without-parkinson-s-disease-66370https://curecurrent.com/trials/lfp-based-parameter-prediction-in-dbs-for-parkinson-s-disease-66371https://curecurrent.com/trials/a-feasibility-study-on-the-safety-and-preliminary-efficacy-of-bilateral-subthalamotomy-using-mrgfus-for-treatment-of-pd-66372https://curecurrent.com/trials/effectiveness-of-stil-orthosis-in-pd-66373https://curecurrent.com/trials/turkish-validation-of-the-parkinson-disease-cognitive-functional-rating-scale-66374https://curecurrent.com/trials/exploring-the-effects-of-spinal-cord-stimulation-in-parkinson-s-disease-66375https://curecurrent.com/trials/vestibular-and-cortical-contributions-to-transitions-in-freezing-of-gait-in-parkinson-s-disease-66376https://curecurrent.com/trials/study-of-favezelimab-coformulated-with-pembrolizumab-mk-4280a-in-participants-with-selected-solid-tumors-mk-4280a-010-66377https://curecurrent.com/trials/adaptive-deep-brain-stimulation-adbs-study-early-adapter-part-ii-66378https://curecurrent.com/trials/cerebellar-stimulation-and-cognitive-control-66379https://curecurrent.com/trials/lenvatinib-in-combination-with-pembrolizumab-versus-treatment-of-physician-s-choice-in-participants-with-advanced-endome-66380https://curecurrent.com/trials/everyday-memory-impairment-in-pd-related-cognitive-decline-66381https://curecurrent.com/trials/intracranial-recordings-to-characterize-action-regulation-mechanisms-66382https://curecurrent.com/trials/neurophysiological-behavioral-and-cognitive-networks-in-movement-disorders-66383https://curecurrent.com/trials/circuit-based-deep-brain-stimulation-for-parkinson-s-disease-udall-clinical-core-66384https://curecurrent.com/trials/ub-312-in-patients-with-synucleinopathies-66385https://curecurrent.com/trials/optimizing-vibrational-therapy-to-improve-gait-and-balance-in-parkinson-s-disease-66386https://curecurrent.com/trials/randomized-placebo-controlled-trial-evaluating-the-efficacy-of-pimavanserin-a-selective-serotonin-5-hydroxytryptamine-2a-66387https://curecurrent.com/trials/citalopram-as-a-posterior-cortical-protective-therapy-in-parkinson-disease-66388https://curecurrent.com/trials/cue2walk-cost-effectiveness-of-automated-freezing-detection-and-provision-of-external-cues-in-comparison-to-usual-care-i-66389https://curecurrent.com/trials/18f-f-dopa-imaging-in-patients-with-autonomic-failure-66390https://curecurrent.com/trials/characterizing-the-pathophysiological-role-of-the-pallido-thalamocortical-motor-pathway-in-parkinson-s-disease-66391https://curecurrent.com/trials/whole-body-vibration-exercise-in-patients-with-parkinson-s-disease-66392https://curecurrent.com/trials/clinical-study-to-evaluate-the-possible-efficacy-of-metformin-in-patients-with-parkinson-s-disease-66393https://curecurrent.com/trials/evaluation-of-neuroinduced-mesenchymal-stem-cells-and-mesenchymal-stem-cell-derived-exosomes-in-patients-with-parkinsoni-66394https://curecurrent.com/trials/parkinson-s-disease-biomarker-study-66395https://curecurrent.com/trials/exercise-to-improve-sleep-in-parkinson-s-disease-66396https://curecurrent.com/trials/effect-of-safinamide-on-sleep-quality-in-patients-with-parkinson-s-disease-66397https://curecurrent.com/trials/allopregnanolone-as-a-regenerative-treatment-for-parkinson-s-disease-66398https://curecurrent.com/trials/essential-amino-acids-and-parkinsons-disease-66399https://curecurrent.com/trials/aerobic-exercise-in-parkinson-s-disease-66400https://curecurrent.com/trials/oxyhydrogen-nanobubble-infusion-as-a-complementary-therapy-in-patients-with-parkinsonism-66401https://curecurrent.com/trials/tackling-anxiety-related-freezing-of-gait-in-people-with-parkinson-s-disease-66402https://curecurrent.com/trials/manual-therapy-in-parkinson-s-disease-66403https://curecurrent.com/trials/low-fidelity-driving-simulator-training-in-parkinson-s-disease-66404https://curecurrent.com/trials/motor-and-cognitive-exercise-in-parkinson-s-disease-66405https://curecurrent.com/trials/spinal-cord-stimulation-for-parkinson-s-disease-rehabilitation-66406https://curecurrent.com/trials/safety-and-efficacy-study-of-pembrolizumab-mk-3475-as-monotherapy-in-the-adjuvant-treatment-of-renal-cell-carcinoma-post-66407https://curecurrent.com/trials/imaging-depression-in-parkinson-s-disease-66408https://curecurrent.com/trials/etiology-phenotype-outcome-pathway-study-on-freezing-of-gait-fog-66409https://curecurrent.com/trials/investigating-the-cholinergic-contribution-to-gait-dysfunction-in-parkinson-s-disease-66410https://curecurrent.com/trials/comparison-of-different-rehabilitation-protocols-in-parkinson-s-disease-with-postural-instability-and-gait-disorders-66411https://curecurrent.com/trials/rad-1601-edge-radiosurgery-for-intractable-essential-tremor-and-tremor-dominant-parkinson-s-disease-66412https://curecurrent.com/trials/investigating-subcortical-contributions-to-speech-sequencing-in-deep-brain-stimulator-recipients-66413https://curecurrent.com/trials/pembrolizumab-placebo-plus-paclitaxel-with-or-without-bevacizumab-for-platinum-resistant-recurrent-ovarian-cancer-mk-347-66414https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-plus-chemotherapy-versus-placebo-plus-chemotherapy-in-participants-with-gastric-or-gastro-66415https://curecurrent.com/trials/metaverse-applications-in-clinical-neurorehabiliation-device-feasibility-66416https://curecurrent.com/trials/community-outreach-for-palliative-engagement-parkinson-disease-66417https://curecurrent.com/trials/study-of-sleep-disorders-in-prodromal-and-definite-parkinsons-disease-66418https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-plus-chemotherapy-versus-placebo-plus-chemotherapy-in-participants-with-gastric-or-gastro-66419https://curecurrent.com/trials/lu-af28996-in-participants-with-parkinson-s-disease-pd-66420https://curecurrent.com/trials/elucidating-the-role-of-cholinergic-degeneration-in-cognitive-fluctuations-in-lewy-body-dementia-66421https://curecurrent.com/trials/light-therapy-for-pd-dose-selection-66422https://curecurrent.com/trials/18f-fd17-pet-imaging-of-synuclein-a-clinical-study-in-synucleinopathy-patients-66423https://curecurrent.com/trials/shanghai-clinical-cohort-parkinson-s-disease-reserve-66424https://curecurrent.com/trials/auricular-vagus-nerve-stimulation-combined-with-rehabilitation-in-parkinson-s-disease-66425https://curecurrent.com/trials/effect-of-striatal-temporal-interference-stimulation-on-language-processing-in-neurodegenerative-diseases-66426https://curecurrent.com/trials/nicergoline-use-in-dysphagia-patients-66427https://curecurrent.com/trials/parkinson-s-disease-enhancing-physical-therapy-with-brain-stimulation-for-treating-postural-instability-66428https://curecurrent.com/trials/sleep-specific-dbs-therapy-in-parkinson-s-disease-66429https://curecurrent.com/trials/percept-transitions-in-fog-and-pd-66430https://curecurrent.com/trials/udall-project-2-aim-2a-c-66431https://curecurrent.com/trials/terazosin-and-parkinson-s-disease-extension-study-66432https://curecurrent.com/trials/effects-of-rtsms-associated-with-treadmill-training-in-patients-with-parkinson-s-disease-66433https://curecurrent.com/trials/validation-of-synuclein-modifications-in-parkinson-s-disorder-evolution-66434https://curecurrent.com/trials/cardiac-changes-in-early-parkinson-s-disease-a-follow-up-study-66435https://curecurrent.com/trials/adrenergic-blockers-for-cardiac-changes-in-early-parkinson-s-disease-protocol-53136-66436https://curecurrent.com/trials/terazosin-effect-on-cardiac-changes-in-early-parkinson-s-disease-66437https://curecurrent.com/trials/a-multicenter-study-to-evaluate-safety-tolerability-and-clinical-responses-of-dsp-1083-into-subjects-with-parkinson-s-di-66438https://curecurrent.com/trials/implementation-and-validation-of-instrumented-stair-climb-test-66439https://curecurrent.com/trials/efficacy-of-a-breathwork-practice-sky-on-well-being-of-individuals-with-parkinson-s-disease-ipd-and-care-partners-66440https://curecurrent.com/trials/comparative-outcomes-of-radiofrequency-ablation-of-concealed-and-manifest-accessory-pathways-a-single-center-retrospecti-66441https://curecurrent.com/trials/turkish-validation-and-reliability-of-the-john-hopkins-in-room-independence-scale-66442https://curecurrent.com/trials/exploration-of-differences-in-metabolite-concentrations-by-7teslas-nmr-spectroscopy-in-striatum-and-subthalamic-nuclei-i-66443https://curecurrent.com/trials/description-of-the-reasons-for-hospitalization-of-patients-with-parkinson-s-disease-following-admission-through-the-adul-66444https://curecurrent.com/trials/black-and-african-americans-connections-to-parkinson-s-disease-blaac-pd-66445https://curecurrent.com/trials/effects-of-rtms-on-balance-performance-and-functional-mobility-in-parkinson-s-disease-66446https://curecurrent.com/trials/pembrolizumab-mk-3475-plus-chemotherapy-versus-placebo-plus-chemotherapy-in-participants-gastric-or-gastroesophageal-jun-66447https://curecurrent.com/trials/pharmacologically-modulating-the-noradrenergic-arousal-system-to-reduce-freezing-of-gait-in-parkinson-s-disease-a-multi-66448https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-pimavanserin-in-patients-with-parkinson-s-disease-psychosis-66449https://curecurrent.com/trials/study-to-assess-effectiveness-and-adverse-events-of-foscarbidopa-foslevodopa-in-adult-participants-with-advanced-parkins-66450https://curecurrent.com/trials/cross-sectional-study-of-vitamin-b6-in-parkinson-s-disease-66451https://curecurrent.com/trials/the-sunnybrook-dementia-study-66452https://curecurrent.com/trials/impact-of-c-mill-rehabilitation-on-the-gut-brain-axis-in-parkinson-s-disease-66453https://curecurrent.com/trials/predictors-of-clinical-outcomes-of-deep-brain-stimulation-in-parkinson-s-disease-66454https://curecurrent.com/trials/visuospatial-and-affective-abilities-in-parkinson-disease-66455https://curecurrent.com/trials/pyridostigmine-for-the-treatment-of-constipation-in-parkinson-disease-66456https://curecurrent.com/trials/exploring-mechanisms-for-neuropsychiatric-symptoms-of-parkinson-disease-using-transcranial-direct-current-stimulation-66457https://curecurrent.com/trials/study-of-chemoradiotherapy-with-or-without-pembrolizumab-mk-3475-for-the-treatment-of-locally-advanced-cervical-cancer-m-66458https://curecurrent.com/trials/gait-physical-activity-and-sleep-in-parkinson-s-disease-66459https://curecurrent.com/trials/double-blind-clinical-trial-of-subthalamic-nucleus-deep-brain-stimulation-in-early-stage-parkinson-s-disease-66460https://curecurrent.com/trials/study-to-investigate-vagus-nerve-stimulation-to-augment-executive-function-in-healthy-and-cognitively-impaired-populatio-66461https://curecurrent.com/trials/in-home-cycling-for-individuals-with-pd-effectiveness-66462https://curecurrent.com/trials/dual-task-cognitive-motor-telerehabilitation-in-persons-with-pd-mci-66463https://curecurrent.com/trials/scan-targeted-epidural-modulation-for-parkinson-s-disease-66464https://curecurrent.com/trials/untreated-parkinson-s-disease-work-up-assessing-resident-microbiota-and-duodenal-barrier-function-66465https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-vs-brentuximab-vedotin-in-participants-with-relapsed-or-refractory-classical-hodgkin-lymp-66466https://curecurrent.com/trials/a-study-of-efficacy-and-safety-of-sacituzumab-tirumotecan-mk-2870-plus-enfortumab-vedotin-ev-with-and-without-pembrolizu-66467https://curecurrent.com/trials/closed-loop-dbs-implanted-rc-s-study-66468https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-for-musculoskeletal-pain-in-patients-with-parkinson-s-disease-66469https://curecurrent.com/trials/vestibulopathy-imbalance-and-gait-disturbances-in-parkinson-disease-66470https://curecurrent.com/trials/a-study-of-pembrolizumab-berahyaluronidase-alfa-mk-3475a-pembrolizumab-formulated-with-berahyaluronidase-alfa-mk-5180-in-66471https://curecurrent.com/trials/low-intensity-focused-ultrasound-for-parkinson-s-disease-66472https://curecurrent.com/trials/role-of-slow-waves-in-the-progression-of-neurodegeneration-in-isolated-rem-sleep-behavior-disorder-66473https://curecurrent.com/trials/understanding-freezing-of-gait-using-brain-signals-and-virtual-reality-66474https://curecurrent.com/trials/evaluation-of-the-safety-of-electrical-spinal-cord-stimulation-in-parkinson-s-patients-presenting-with-painful-camptocor-66475https://curecurrent.com/trials/detection-of-internal-tremors-by-oscillometry-in-parkinson-s-patient-66476https://curecurrent.com/trials/feasibility-and-preliminary-effects-of-the-walking-tall-app-for-home-based-gait-training-in-parkinson-s-disease-a-pilot-66477https://curecurrent.com/trials/social-qol-behaviors-in-parkinson-s-disease-66478https://curecurrent.com/trials/effects-of-vagal-nerve-stimulation-on-leg-muscle-activity-and-posture-in-parkinson-s-disease-66479https://curecurrent.com/trials/clinical-efficacy-of-intermittent-theta-burst-transcranial-magnetic-stimulation-with-different-modes-on-parkinson-s-dise-66480https://curecurrent.com/trials/dash-diet-triglycerides-and-aip-in-parkinson-s-disease-66481https://curecurrent.com/trials/clinical-validity-of-the-danu-sports-system-for-gait-and-balance-assessment-in-parkinson-s-disease-66482https://curecurrent.com/trials/effects-of-magnetic-stimulation-of-the-dorsal-spinal-cord-on-gait-in-patients-with-parkinson-s-disease-and-deep-brain-st-66483https://curecurrent.com/trials/tadalafil-and-pembrolizumab-in-recurrent-or-metastatic-head-and-neck-cancer-66484https://curecurrent.com/trials/objective-mobility-assessment-using-wearable-technology-for-clinical-application-in-parkinson-s-disease-from-validation-66485https://curecurrent.com/trials/colonic-tissue-biopsy-detection-of-phosphorylated-alpha-synuclein-for-parkinson-s-diagnosis-or-rem-sleep-behavior-disord-66486https://curecurrent.com/trials/intranasal-insulin-in-parkinson-s-disease-66487https://curecurrent.com/trials/stereotactic-intracerebral-injection-of-allogenic-ipsc-daps-in-patients-with-parkinson-s-disease-66488https://curecurrent.com/trials/quantification-of-phosphorylated-alpha-synuclein-in-cutaneous-biopsies-as-a-prospective-biomarker-in-parkinson-s-disease-66489https://curecurrent.com/trials/neural-correlates-of-motor-and-psychiatric-fluctuations-in-parkinson-s-disease-66490https://curecurrent.com/trials/colonoscopic-detection-of-phosphorylated-alpha-synuclein-for-parkinson-s-diagnosis-66491https://curecurrent.com/trials/optimistic-and-pessimistic-dopamine-signals-in-the-human-brain-a-mapping-and-modelling-study-in-health-and-parkinson-s-d-66492https://curecurrent.com/trials/italian-translation-and-validation-of-the-gids-pd-scale-for-parkinson-s-disease-66493https://curecurrent.com/trials/effects-of-protective-step-training-on-proactive-and-reactive-motor-adaptations-in-parkinson-s-disease-patients-66494https://curecurrent.com/trials/expanded-access-to-tavapadon-66495https://curecurrent.com/trials/home-based-calligraphic-handwriting-exercises-in-parkinson-s-disease-66496https://curecurrent.com/trials/prtms-as-an-intervention-for-bradykinesia-in-parkinson-s-disease-66497https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-pembrolizumab-mk-3475-coformulated-with-berahyaluronidase-alfa-mk-3475a-i-66498https://curecurrent.com/trials/18f-dopa-ii-pet-imaging-optimization-66499https://curecurrent.com/trials/safety-and-efficacy-study-of-pembrolizumab-mk-3475-combined-with-lenvatinib-mk-7902-e7080-as-first-line-intervention-in-66500https://curecurrent.com/trials/effect-of-repetitive-bihemispheric-anodal-transcranial-direct-current-stimulation-on-motor-function-of-patients-with-par-66501https://curecurrent.com/trials/effects-of-directional-subthalamic-deep-brain-stimulation-on-gait-and-balance-in-parkinson-s-disease-patients-66502https://curecurrent.com/trials/study-on-artificial-intelligence-based-facial-and-speech-related-patterns-in-parkinson-s-disease-and-their-digital-bioma-66503https://curecurrent.com/trials/medico-economic-evaluation-rehabilitation-by-serious-games-at-home-for-the-management-of-patients-with-parkinson-s-disea-66504https://curecurrent.com/trials/safety-and-efficacy-of-lenvatinib-e7080-mk-7902-in-combination-with-pembrolizumab-mk-3475-versus-lenvatinib-as-first-lin-66505https://curecurrent.com/trials/conservative-iron-chelation-as-a-disease-modifying-strategy-in-parkinson-s-disease-66506https://curecurrent.com/trials/evaluation-of-the-effects-of-aquatic-therapy-on-activities-of-daily-living-walking-balance-posture-pain-and-depression-i-66507https://curecurrent.com/trials/study-of-lenvatinib-mk-7902-e7080-in-combination-with-pembrolizumab-mk-3475-versus-standard-of-care-in-participants-with-66508https://curecurrent.com/trials/study-of-first-line-pembrolizumab-mk-3475-with-lenvatinib-mk-7902-e7080-in-urothelial-carcinoma-cisplatin-ineligible-par-66509https://curecurrent.com/trials/lifup-for-treatment-of-motor-deficits-in-parkinson-s-disease-66510https://curecurrent.com/trials/efficacy-and-safety-study-of-first-line-treatment-with-pembrolizumab-mk-3475-plus-chemotherapy-versus-placebo-plus-chemo-66511https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-or-placebo-with-chemoradiation-in-participants-with-locally-advanced-head-and-neck-squamo-66512https://curecurrent.com/trials/cognitive-recovery-via-sensor-based-robotic-upper-limb-rehabilitation-in-neurological-disorders-66513https://curecurrent.com/trials/comparative-effects-of-virtual-reality-and-proprioceptive-neuromuscular-facilitation-in-patients-with-parkinson-s-diseas-66514https://curecurrent.com/trials/transcranial-direct-current-stimulation-for-motor-function-and-fatigue-in-pd-66515https://curecurrent.com/trials/cognitive-effects-of-exercise-in-parkinson-s-disease-66516https://curecurrent.com/trials/developing-immersive-gamification-technology-systems-for-the-rehabilitation-management-of-adults-with-parkinson-s-diseas-66517https://curecurrent.com/trials/effect-of-istradefylline-treatment-on-behavioral-measures-of-apathy-in-parkinson-s-disease-66518https://curecurrent.com/trials/low-versus-high-load-training-and-parkinson-s-disease-66519https://curecurrent.com/trials/effects-of-transcranial-direct-current-stimulation-combined-with-nordic-walking-on-gait-and-balance-in-parkinson-s-disea-66520https://curecurrent.com/trials/pilot-study-of-robotic-spinal-mobilization-in-parkinson-s-disease-66521https://curecurrent.com/trials/rhythmic-auditory-stimulaton-using-personalized-music-therapy-in-parkinson-s-disease-66522https://curecurrent.com/trials/feasibility-study-assessing-the-effect-of-carbidopa-levodopa-ratio-on-orthostatic-hypotension-in-multiple-system-atrophy-66523https://curecurrent.com/trials/adaptive-vs-continuous-subthalamic-nucleus-deep-brain-stimulation-in-parkinson-s-disease-66524https://curecurrent.com/trials/effect-of-melatonin-on-oxidative-stress-parameters-in-levodopa-treated-parkinson-s-disease-patients-66525https://curecurrent.com/trials/anti-diabetic-medications-to-fight-pd-and-lbd-66526https://curecurrent.com/trials/effects-of-exercise-with-visual-feedback-in-parkinson-s-disease-66527https://curecurrent.com/trials/virtual-tes-device-treatment-for-parkinson-s-disease-motor-symptoms-66528https://curecurrent.com/trials/turkish-adaptation-of-parkinson-s-disease-quality-of-life-7-pdqol7-questionnaire-66529https://curecurrent.com/trials/examination-of-factors-associated-with-fatigue-in-individuals-diagnosed-with-parkinson-s-disease-66530https://curecurrent.com/trials/facilitating-diagnostics-and-prognostics-of-parkinsonian-syndromes-using-neuroimaging-66531https://curecurrent.com/trials/comparing-biomarker-guided-dbs-programming-with-standard-clinical-monopolar-programming-66532https://curecurrent.com/trials/effects-of-pallidal-deep-brain-stimulation-location-on-motor-impairment-in-parkinson-s-disease-66533https://curecurrent.com/trials/tavns-on-functional-mobility-in-people-with-dp-66534https://curecurrent.com/trials/circuit-based-deep-brain-stimulation-for-parkinson-s-disease-p1a2-3-catalyst-66535https://curecurrent.com/trials/mr-guided-focused-ultrasound-plus-gcase-66536https://curecurrent.com/trials/parkin-mutations-and-their-functional-consequences-66537https://curecurrent.com/trials/myrosinase-bioactivated-gglucoraphanin-for-the-treatment-of-neurodegenerative-diseases-gra-myr-nd-66538https://curecurrent.com/trials/voice-activated-intelligent-personal-assistant-vipa-intervention-for-people-with-parkinson-s-disease-66539https://curecurrent.com/trials/microstructural-and-sodium-7-tesla-brain-mri-in-idiopathic-rem-sleep-behaviour-disorder-66540https://curecurrent.com/trials/fexofenadine-as-adjuvant-therapy-in-parkinson-disease-66541https://curecurrent.com/trials/attributional-style-and-parkinson-s-disease-66542https://curecurrent.com/trials/gyko-based-l-test-reliability-in-parkinson-s-disease-66543https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-neural-stem-cells-in-patients-with-parkinson-s-disease-66544https://curecurrent.com/trials/understanding-how-movements-are-transferred-from-task-to-task-in-parkinson-s-disease-66545https://curecurrent.com/trials/the-effect-of-proprioceptive-neuromuscular-facilitation-on-trunk-mobility-gait-fear-of-falling-and-quality-of-life-in-in-66546https://curecurrent.com/trials/slowing-cognitive-decline-in-alpha-synucleinopathies-by-enhancing-physical-activity-66547https://curecurrent.com/trials/efficacy-and-safety-of-tj0113-capsule-in-patients-with-parkinson-s-disease-66548https://curecurrent.com/trials/control-cohort-ctrl-coh-66549https://curecurrent.com/trials/safety-and-efficacy-study-of-parkinson-s-disease-gene-therapy-drug-bbm-p002-66550https://curecurrent.com/trials/cognitive-disparities-in-parkinson-s-disease-66551https://curecurrent.com/trials/a-study-of-suvecaltamide-in-adults-with-moderate-to-severe-residual-tremor-in-parkinson-s-disease-66552https://curecurrent.com/trials/improvisational-dance-for-parkinson-disease-66553https://curecurrent.com/trials/pairing-subjective-patient-rating-and-dbs-programming-66554https://curecurrent.com/trials/the-motor-network-in-essential-tremor-mechanisms-of-therapy-66555https://curecurrent.com/trials/c-mill-virtual-reality-applied-rehabilitation-and-classical-rehabilitation-on-gait-and-balance-in-parkinson-s-patients-66556https://curecurrent.com/trials/a-clinical-study-of-intismeran-autogene-v940-treatment-and-pembrolizumab-in-people-with-bladder-cancer-v940-005-interpat-66557https://curecurrent.com/trials/partnered-dance-aerobic-exercise-as-a-neuroprotective-motor-and-cognitive-intervention-in-parkinson-s-disease-66558https://curecurrent.com/trials/anterior-foot-wedge-with-neuromuscular-training-for-balance-in-parkinson-s-disease-66559https://curecurrent.com/trials/tame-pd-physical-therapy-atomoxetine-and-methylphenidate-to-enhance-gait-and-balance-in-parkinson-s-disease-66560https://curecurrent.com/trials/patient-engagement-investigation-of-nms-assist-66561https://curecurrent.com/trials/empower-your-mind-to-embrace-your-life-an-online-act-intervention-for-young-onset-parkinson-s-disease-66562https://curecurrent.com/trials/abbott-dbs-post-market-study-of-outcomes-for-indications-over-time-66563https://curecurrent.com/trials/menthol-for-improving-movement-and-sleep-in-parkinson-s-disease-patients-66564https://curecurrent.com/trials/deep-brain-stimulation-for-visuomotor-function-in-parkinson-s-disease-66565https://curecurrent.com/trials/mrgfus-for-parkinson-s-tremor-66566https://curecurrent.com/trials/an-rct-of-a-telemedicine-intervention-for-hypokinetic-dysarthria-in-pd-66567https://curecurrent.com/trials/accelerated-tms-for-freezing-of-gait-in-parkinson-s-disease-66568https://curecurrent.com/trials/non-invasive-brain-mapping-of-movement-facilitation-in-parkinson-s-disease-66569https://curecurrent.com/trials/prp-and-pbd-vsel-stem-cell-therapy-for-parkinson-s-disease-66570https://curecurrent.com/trials/spinal-cord-stimulation-in-the-treatment-of-parkinson-s-disease-66571https://curecurrent.com/trials/bilateral-subthalamic-stimulation-in-pd-patients-with-impulse-control-disorders-stimpulsecontrol-66572https://curecurrent.com/trials/the-effect-of-rtms-over-the-sma-on-gait-performance-in-parkinson-s-disease-66573https://curecurrent.com/trials/the-ultrasonographic-evaluation-of-abdominal-accessory-respiratory-muscle-thickness-in-patients-with-parkinson-s-disease-66574https://curecurrent.com/trials/enhanced-tai-chi-for-parkinson-s-disease-enhanced-tai-chi-pd-66575https://curecurrent.com/trials/study-on-the-efficacy-of-temporal-interference-stimulation-tis-for-parkinson-s-disease-66576https://curecurrent.com/trials/a-high-density-microelectrode-for-human-neuronal-recordings-66577https://curecurrent.com/trials/dual-task-improvement-in-parkinson-s-via-rtms-66578https://curecurrent.com/trials/wearable-airbag-technology-to-mitigate-falls-in-individuals-with-high-fall-risk-66579https://curecurrent.com/trials/clinical-study-to-evaluate-xs411-in-treatment-of-early-onset-parkinson-s-disease-66580https://curecurrent.com/trials/baduanjin-qigong-exercise-in-patients-with-parkinson-s-disease-66581https://curecurrent.com/trials/an-observational-study-of-patients-with-moderate-parkinson-s-disease-66582https://curecurrent.com/trials/upper-extremity-functional-skills-in-patients-with-parkinson-disease-pwpd-66583https://curecurrent.com/trials/pet-imaging-evaluation-of-11c-sy08-66584https://curecurrent.com/trials/safety-and-efficacy-study-of-pembrolizumab-mk-3475-combined-with-lenvatinib-mk-7902-e7080-as-first-line-intervention-in-66585https://curecurrent.com/trials/relationship-between-immunosuppressive-treatment-status-and-clinical-course-of-parkinson-s-disease-66586https://curecurrent.com/trials/open-label-trial-in-parkinson-s-disease-pd-66587https://curecurrent.com/trials/the-impact-of-exercise-on-subthalamic-nucleus-neural-activity-in-parkinson-s-disease-66588https://curecurrent.com/trials/evaluation-of-a-new-communication-aid-tool-to-favor-global-patient-centered-care-66589https://curecurrent.com/trials/study-of-dysarthria-and-the-appearance-of-non-dopaminergic-signs-in-idiopathic-parkinson-s-disease-66590https://curecurrent.com/trials/biological-determinants-and-neural-compensation-of-dysphagia-in-parkinson-s-disease-66591https://curecurrent.com/trials/movement-improves-brain-health-and-cognition-in-parkinson-s-disease-66592https://curecurrent.com/trials/prevention-in-pd-study-66593https://curecurrent.com/trials/validation-of-the-neuropsychiatric-fluctuations-scale-efn-valid-66594https://curecurrent.com/trials/tms-related-measures-as-biomarker-of-cognitive-impairment-in-pd-66595https://curecurrent.com/trials/describe-to-better-understand-the-mealtime-of-people-with-parkinson-s-disease-dependent-on-food-intake-66596https://curecurrent.com/trials/compensatory-mechanisms-in-parkinson-disease-pd-66597https://curecurrent.com/trials/a-study-assessing-the-safety-of-oral-ath-399a-in-healthy-adult-participants-66598https://curecurrent.com/trials/a-randomized-double-blind-active-controlled-crossover-trial-of-respiratory-gated-versus-non-gated-transcutaneous-auricul-66599https://curecurrent.com/trials/a-novel-balance-program-to-improve-balance-in-people-with-parkinson-s-disease-66600https://curecurrent.com/trials/postural-sway-of-trunk-and-upper-extremity-functional-skills-in-atient-with-parkinson-disease-pwpd-66601https://curecurrent.com/trials/cortical-network-modulation-by-subthalamic-nucleus-dbs-66602https://curecurrent.com/trials/tdcs-as-treatment-for-motor-function-66603https://curecurrent.com/trials/triggering-motor-memory-consolidation-in-pd-complex-practice-of-fine-motor-tasks-and-brain-activity-during-learning-66604https://curecurrent.com/trials/safety-and-usability-of-the-cionic-neural-sleeve-for-parkinson-s-disease-66605https://curecurrent.com/trials/cortical-correlates-of-gait-in-parkinson-s-disease-impact-of-medication-and-cueing-66606https://curecurrent.com/trials/a-study-of-combination-therapies-with-or-without-pembrolizumab-mk-3475-and-or-chemotherapy-in-participants-with-advanced-66607https://curecurrent.com/trials/study-on-preliminary-safety-and-efficacy-of-adaptive-dbs-aligned-to-locomotor-states-to-improve-locomotor-functions-in-p-66608https://curecurrent.com/trials/combining-vns-with-pt-interventions-for-individuals-with-pd-66609https://curecurrent.com/trials/a-trial-to-determine-the-safety-and-tolerability-of-transplanted-stem-cell-derived-dopamine-neurons-to-the-brains-of-ind-66610https://curecurrent.com/trials/deep-brain-stimulation-for-parkinson-s-disease-probabilistic-stn-targeting-under-general-anaesthesia-without-micro-elect-66611https://curecurrent.com/trials/physiological-effects-of-nutritional-support-in-patients-with-parkinson-s-disease-66612https://curecurrent.com/trials/efficacy-safety-tolerability-and-biomarker-effects-of-gt-02287-in-early-parkinson-s-disease-66613https://curecurrent.com/trials/an-open-label-observational-long-term-follow-up-study-evaluating-the-safety-and-efficacy-of-rgl-193-putamen-injection-in-66614https://curecurrent.com/trials/action-regulation-behavioral-66615https://curecurrent.com/trials/design-and-validation-of-innovative-strategies-based-on-dual-task-approach-66616https://curecurrent.com/trials/coordinated-reset-deep-brain-stimulation-66617https://curecurrent.com/trials/effects-of-otago-and-frenkel-s-exercises-on-strengthening-of-antigravity-muscles-in-parkinson-s-disease-66618https://curecurrent.com/trials/comparison-of-vestibular-and-dual-task-rehabilitation-in-parkinson-s-disease-66619https://curecurrent.com/trials/effectiveness-and-safety-of-directional-deep-brain-stimulation-for-parkinson-s-disease-66620https://curecurrent.com/trials/the-effect-of-balance-focused-exercise-programme-in-enhancing-the-solus-muscle-activation-during-gait-initiation-for-peo-66621https://curecurrent.com/trials/clinical-validation-of-ai-powered-smart-vehicle-assisted-gait-training-in-neurodegenerative-disorders-66622https://curecurrent.com/trials/revision-of-deep-brain-stimulator-in-patients-with-parkinson-s-disease-66623https://curecurrent.com/trials/vinpocetine-in-patients-with-parkinsonian-disease-66624https://curecurrent.com/trials/biomarker-assessments-of-leukine-during-treatment-of-parkinson-s-disease-66625https://curecurrent.com/trials/temporal-expectations-in-parkinson-s-disease-66626https://curecurrent.com/trials/whole-body-photobiomodulation-for-motor-and-cognitive-changes-in-parkinson-s-disease-66627https://curecurrent.com/trials/kynurenine-pathway-in-parkinson-s-disease-66628https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-regulating-slow-wave-to-delay-the-progression-of-parkinson-s-disease-66629https://curecurrent.com/trials/expiratory-muscle-training-in-parkinson-s-disease-with-forward-trunk-flexion-66630https://curecurrent.com/trials/ketamine-for-the-treatment-of-depression-in-parkinson-s-disease-66631https://curecurrent.com/trials/celecoxib-in-parkinson-disease-as-adjuvant-therapy-66632https://curecurrent.com/trials/monitoring-of-mobility-of-parkinson-s-patients-for-therapeutic-purposes-clinical-trial-66633https://curecurrent.com/trials/early-longitudinal-imaging-in-the-parkinson-s-progressive-marker-initiative-ppmi-using-18f-av-133-ppmi-av-133-prodromal-66634https://curecurrent.com/trials/efficacy-of-ericksonian-hypnosis-in-the-management-of-chronic-pain-related-to-parkinson-s-disease-66635https://curecurrent.com/trials/markers-of-disease-progression-and-gait-within-the-parkinsonian-population-66636https://curecurrent.com/trials/lenvatinib-e7080-mk-7902-in-combination-with-pembrolizumab-mk-3475-vs-standard-chemotherapy-and-lenvatinib-monotherapy-i-66637https://curecurrent.com/trials/fall-risk-assessment-in-parkinson-s-disease-using-kinetikos-health-66638https://curecurrent.com/trials/serious-games-rehabilitation-programme-to-treat-gait-and-balance-disorders-in-pd-patients-66639https://curecurrent.com/trials/comparison-of-different-non-invasive-electrical-stimulation-protocols-to-facilitate-rehabilitation-in-parkinson-s-diseas-66640https://curecurrent.com/trials/application-of-smart-electric-vehicles-in-analyzing-gait-abnormalities-in-patients-with-neurodegenerative-diseases-66641https://curecurrent.com/trials/use-of-immersive-virtual-reality-and-therapeutic-exercise-as-complementary-therapy-in-mild-to-moderate-parkinson-s-disea-66642https://curecurrent.com/trials/pembrolizumab-plus-lenvatinib-for-first-line-advanced-metastatic-non-clear-cell-renal-cell-carcinoma-1l-nccrcc-mk-3475-b-66643https://curecurrent.com/trials/identification-of-risk-factors-parkinson-s-disease-by-convergence-strategy-66644https://curecurrent.com/trials/effect-of-mediterranean-diet-on-nutrition-in-parkinson-s-disease-patients-with-bilateral-subthalamic-deep-brain-stimulat-66645https://curecurrent.com/trials/online-dance-versus-therapeutic-exercise-for-parkinson-disease-66646https://curecurrent.com/trials/clinical-validation-of-dystonianet-deep-learning-platform-for-diagnosis-of-isolated-dystonia-66647https://curecurrent.com/trials/tocotrienols-in-parkinson-s-disease-pd-66648https://curecurrent.com/trials/stimpulsecontrol-ancillary-speech-study-66649https://curecurrent.com/trials/investigating-inhibitory-control-networks-in-parkinson-s-disease-66650https://curecurrent.com/trials/psa-versus-stn-dbs-for-td-pd-66651https://curecurrent.com/trials/empathy-and-self-compassion-in-parkinson-s-disease-patients-and-caregivers-66652https://curecurrent.com/trials/effect-of-visual-feedback-from-the-spirogym-mobile-application-66653https://curecurrent.com/trials/transforming-parkinson-s-care-with-predictive-algorithms-66654https://curecurrent.com/trials/globus-pallidus-stimulation-to-treat-insomnia-66655https://curecurrent.com/trials/study-to-evaluate-the-effect-of-lixisenatide-in-patient-with-parkinson-s-disease-66656https://curecurrent.com/trials/continuous-electrical-neuromodulation-of-the-globus-pallidus-intern-in-parkinson-s-disease-by-the-directional-electrode-66657https://curecurrent.com/trials/dbs-recordings-to-characterize-movement-facilitation-in-parkinson-s-disease-66658https://curecurrent.com/trials/transcutaneous-electrical-nerve-stimulation-tens-for-lower-urinary-tract-disorders-in-parkinson-s-syndrome-66659https://curecurrent.com/trials/a-study-of-coformulated-favezelimab-pembrolizumab-mk-4280a-versus-standard-of-care-in-subjects-with-previously-treated-m-66660https://curecurrent.com/trials/peer-partners-to-improve-physical-activity-in-older-latino-and-latina-adults-with-parkinson-s-disease-66661https://curecurrent.com/trials/subthalamic-nucleus-versus-globus-pallidal-internus-deep-brain-stimulation-for-parkinson-disease-66662https://curecurrent.com/trials/non-invasive-fundus-retinal-detection-technology-for-early-diagnosis-of-parkinson-s-disease-66663https://curecurrent.com/trials/home-use-study-of-targeted-mechanical-stimulation-for-tremor-relief-66664https://curecurrent.com/trials/effect-of-rtms-of-the-cerebellum-on-parkinson-s-disease-66665https://curecurrent.com/trials/metformin-in-parkinson-disease-66666https://curecurrent.com/trials/clinico-pathologic-genetic-imaging-study-of-neurodegenerative-and-related-disorders-66667https://curecurrent.com/trials/flexible-dose-trial-in-early-parkinson-s-disease-pd-66668https://curecurrent.com/trials/cortical-stimulation-to-treat-mood-and-behavioral-symptoms-in-parkinson-s-disease-patients-66669https://curecurrent.com/trials/tacs-modulates-speech-and-cognitive-impairments-in-people-with-pd-by-targeting-the-medial-frontal-cortex-66670https://curecurrent.com/trials/application-of-thoracic-epidural-scs-for-managing-fog-in-patients-with-advanced-parkinson-s-disease-66671https://curecurrent.com/trials/multidisciplinary-study-of-novel-nmda-modulation-for-neurodegenerative-disorder-66672https://curecurrent.com/trials/study-of-biodistribution-metabolism-excretion-and-brain-uptake-of-11c-hy-2-15-66673https://curecurrent.com/trials/6-month-follow-up-study-on-the-changes-of-postural-stability-in-parkinsonian-patients-in-response-to-high-frequency-tms-66674https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-trial-of-ikt-148009-in-untreated-parkinson-s-disease-66675https://curecurrent.com/trials/18f-aci-15916-pet-in-synucleinopathies-66676https://curecurrent.com/trials/clozapine-related-immunodeficiency-in-parkinsons-disease-66677https://curecurrent.com/trials/respiratory-gated-transcutaneous-auricular-vagus-nerve-stimulation-for-improving-apathy-in-parkinson-s-disease-66678https://curecurrent.com/trials/dual-target-high-dose-tms-for-pd-patients-with-fog-66679https://curecurrent.com/trials/mindfulness-based-stress-reduction-for-parkinson-s-disease-a-longitudinal-study-66680https://curecurrent.com/trials/mechanical-determinants-of-upper-limbs-oscillation-during-gait-66681https://curecurrent.com/trials/study-to-assess-pdm608-in-healthy-adult-subjects-66682https://curecurrent.com/trials/influence-of-autonomy-on-motor-learning-in-people-with-parkinson-s-disease-66683https://curecurrent.com/trials/a-study-to-test-the-safety-tolerability-and-blood-levels-of-ucb0022-in-healthy-participants-and-participants-with-parkin-66684https://curecurrent.com/trials/serious-game-for-parkinson-s-disease-patients-66685https://curecurrent.com/trials/superior-colliculus-activity-in-parkinson-disease-a-potential-marker-66686https://curecurrent.com/trials/efficacy-of-cognitive-rehabilitation-using-virtual-reality-and-computer-based-cognitive-stimulation-on-cognitive-impairm-66687https://curecurrent.com/trials/clinical-research-on-stem-cell-therapy-for-parkinson-s-disease-66688https://curecurrent.com/trials/18f-lbt-999-pet-compared-to-123i-fp-cit-spect-to-distinguish-between-parkinson-s-diseases-and-essential-tremor-66689https://curecurrent.com/trials/mobility-in-daily-life-and-falls-in-parkinson-s-disease-potential-for-rehabilitation-66690https://curecurrent.com/trials/effectiveness-of-video-based-upper-extremity-exercise-program-in-parkinson-s-disease-66691https://curecurrent.com/trials/music-therapy-to-prevent-hospital-acquired-delirium-in-parkinson-s-disease-and-dementia-with-lewy-bodies-66692https://curecurrent.com/trials/phase-2-trial-of-tributyrin-in-people-with-parkinson-s-disease-and-cognitive-impairments-66693https://curecurrent.com/trials/bright-light-therapy-for-non-motor-symptoms-in-parkinson-s-disease-66694https://curecurrent.com/trials/biomarker-validation-following-sargramostim-treatment-in-parkinson-s-disease-66695https://curecurrent.com/trials/utilizing-neural-signatures-and-virtual-reality-to-advance-dbs-programming-66696https://curecurrent.com/trials/a-18-month-study-to-evaluate-the-efficacy-safety-tolerability-and-pharmacokinetics-of-oral-ucb0599-in-study-participants-66697https://curecurrent.com/trials/a-phase-1b-study-of-the-nlrp3-inhibitor-vent-02-in-patients-with-mild-to-moderate-parkinson-s-disease-66698https://curecurrent.com/trials/study-of-intratumoral-it-ulevostinag-mk-1454-in-combination-with-intravenous-iv-pembrolizumab-mk-3475-compared-to-iv-pem-66699https://curecurrent.com/trials/study-of-ulevostinag-mk-1454-alone-or-in-combination-with-pembrolizumab-mk-3475-in-participants-with-advanced-metastatic-66700https://curecurrent.com/trials/substudy-02d-safety-and-efficacy-of-pembrolizumab-in-combination-with-investigational-agents-or-pembrolizumab-alone-in-p-66701https://curecurrent.com/trials/rtms-treatment-of-dysphagia-in-parkinson-s-patients-66702https://curecurrent.com/trials/analysis-and-suppression-of-tremor-during-grasp-using-ultrasound-imaging-and-electrical-stimulation-66703https://curecurrent.com/trials/real-world-patient-experiences-using-continuous-subcutaneous-apomorphine-infusion-onapgotm-in-the-united-states-66704https://curecurrent.com/trials/study-of-gastrointestinal-dysfunction-and-enteric-neural-pathology-in-patients-with-parkinson-s-disease-66705https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-staccato-apomorphine-az-009-in-patients-with-parkinson-s-disease-experienci-66706https://curecurrent.com/trials/stimulus-evoked-directional-field-potentials-to-guide-subthalamic-and-pallidal-dbs-for-pd-66707https://curecurrent.com/trials/motor-training-in-pd-66708https://curecurrent.com/trials/cognitive-decline-following-deep-brain-stimulation-a-dbs-fmri-study-66709https://curecurrent.com/trials/effects-of-midodrine-and-droxidopa-on-splanchnic-capacitance-in-autonomic-failure-66710https://curecurrent.com/trials/study-of-vibostolimab-alone-and-in-combination-with-pembrolizumab-in-advanced-solid-tumors-mk-7684-001-keyvibe-001-66711https://curecurrent.com/trials/personal-kinetigraph-clinical-validation-study-66712https://curecurrent.com/trials/novel-dbs-device-in-parkinson-s-disease-66713https://curecurrent.com/trials/combining-aerobic-exercise-and-virtual-reality-for-cognitive-motor-rehabilitation-in-pd-66714https://curecurrent.com/trials/freezing-in-parkinson-s-disease-66715https://curecurrent.com/trials/function-based-accelerated-stimulation-therapy-fast-therapy-for-freezing-of-gait-fog-after-parkinson-s-disease-pd-66716https://curecurrent.com/trials/molecular-and-functional-imaging-in-monogenic-pd-66717https://curecurrent.com/trials/molecular-imaging-of-inflammation-in-parkinson-s-disease-using-lps-and-tspo-pet-mr-66718https://curecurrent.com/trials/parkinson-s-disease-and-movement-disorders-clinical-database-66719https://curecurrent.com/trials/exploratory-study-of-the-expression-of-the-serotonergic-5-ht4-receptor-in-parkinson-s-disease-66720https://curecurrent.com/trials/longitudinal-investigation-of-i2bs-in-pd-66721https://curecurrent.com/trials/serotonin-release-in-premotor-and-motor-pd-66722https://curecurrent.com/trials/chemoradiation-vs-immunotherapy-and-radiation-for-head-and-neck-cancer-66723https://curecurrent.com/trials/the-effects-of-dual-task-training-with-different-task-priorities-on-physical-performance-and-cognitive-status-in-patient-66724https://curecurrent.com/trials/movement-2-music-lakeshore-examination-of-activity-disability-and-exercise-response-study-66725https://curecurrent.com/trials/observational-case-series-of-patients-with-parkinson-s-disease-pd-attending-a-complementary-medicine-neuro-degenerative-66726https://curecurrent.com/trials/edmond-j-safra-accelerating-clinical-trials-in-parkinson-s-disease-a-multiarm-multi-stage-platform-trial-66727https://curecurrent.com/trials/ab-1005-long-term-follow-up-study-66728https://curecurrent.com/trials/video-oculography-and-parkinson-s-disease-66729https://curecurrent.com/trials/non-invasive-diagnosis-of-parkinson-s-disease-66730https://curecurrent.com/trials/mindfulness-based-intervention-for-people-with-parkinsonian-tremor-66731https://curecurrent.com/trials/dual-task-augmented-reality-for-pd-dbs-66732https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-or-placebo-given-with-best-supportive-care-in-asian-participants-with-previously-treated-66733https://curecurrent.com/trials/observational-study-on-functional-overlay-in-patients-with-movement-disorders-66734https://curecurrent.com/trials/intermediate-size-expanded-access-protocol-using-autologous-hb-admscs-for-the-treatment-of-parkinson-s-disease-66735https://curecurrent.com/trials/proactive-and-integrated-management-and-empowerment-in-parkinson-s-disease-prime-uk-a-new-model-of-care-prime-rct-66736https://curecurrent.com/trials/novel-paradigms-of-deep-brain-stimulation-for-movement-disorders-66737https://curecurrent.com/trials/intermediate-size-patient-population-expanded-access-ind-for-the-treatment-of-patients-with-parkinson-s-disease-66738https://curecurrent.com/trials/chief-pd-cholinesterase-inhibitor-to-prevent-falls-in-parkinson-s-disease-66739https://curecurrent.com/trials/an-online-physical-activity-coaching-intervention-for-people-with-pd-in-qatar-66740https://curecurrent.com/trials/a-randomized-controlled-trial-of-nicotinamide-riboside-supplementation-in-early-parkinson-s-disease-66741https://curecurrent.com/trials/effects-of-motor-imagery-training-66742https://curecurrent.com/trials/ai-based-progression-and-medication-response-prediction-study-in-parkinson-s-disease-66743https://curecurrent.com/trials/rehabilitation-of-airway-protection-in-parkinson-s-disease-66744https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-biib094-in-adults-with-parkinson-s-disease-66745https://curecurrent.com/trials/consensus-statements-on-deep-brain-stimulation-in-patients-with-parkinson-s-disease-66746https://curecurrent.com/trials/dbs-virtual-learning-experience-66747https://curecurrent.com/trials/influence-of-glucose-on-metabolism-and-clinical-symptoms-of-patients-with-parkinson-s-disease-66748https://curecurrent.com/trials/prodromal-alpha-synuclein-screening-in-parkinson-s-disease-study-66749https://curecurrent.com/trials/brain-machine-interface-for-freezing-of-gait-66750https://curecurrent.com/trials/physiotherapy-and-deep-brain-stimulation-in-parkinson-s-disease-66751https://curecurrent.com/trials/perception-in-parkinson-s-disease-66752https://curecurrent.com/trials/the-benefits-of-nature-for-mood-and-cognition-in-persons-with-and-without-parkinson-s-disease-66753https://curecurrent.com/trials/gdnf-gene-therapy-for-parkinson-s-disease-66754https://curecurrent.com/trials/multimodal-artificial-intelligence-based-fall-risk-prediction-in-parkinson-s-disease-66755https://curecurrent.com/trials/effect-of-meditation-and-controls-and-subjects-with-parkinson-s-disease-on-brain-activity-measured-by-fmri-with-fdopa-66756https://curecurrent.com/trials/biomarkers-of-risk-of-parkinson-disease-66757https://curecurrent.com/trials/deep-brain-stimulation-and-parkinson-s-disease-66758https://curecurrent.com/trials/reliability-and-validity-study-of-the-turkish-version-of-the-parkinson-s-disease-dyskinesia-scale-pdys-26-66759https://curecurrent.com/trials/neocortical-microarchitecture-of-executive-function-66760https://curecurrent.com/trials/gut-microbiota-dysbiosis-and-translocation-during-ibd-and-parkinson-66761https://curecurrent.com/trials/towards-noninvasive-dbs-of-the-basal-ganglia-in-parkinson-s-disease-using-tus-66762https://curecurrent.com/trials/modulate-tremor-severity-with-low-intensity-focused-ultrasound-stimulation-targeting-the-deep-nucleus-of-patients-with-r-66763https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-sage-718-in-participants-with-parkinson-s-disease-mild-cognitive-impa-66764https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-sage-718-in-participants-with-parkinson-s-disease-cognitive-impairment-66765https://curecurrent.com/trials/a-phase-ib-trial-of-combined-febuxostat-and-inosine-therapy-in-patients-with-parkinson-s-disease-66766https://curecurrent.com/trials/clinical-study-of-her-096-in-healthy-volunteer-subjects-and-patients-with-parkinson-s-disease-66767https://curecurrent.com/trials/role-of-silymarin-in-neuroprotection-and-symptom-management-in-parkinson-s-disease-66768https://curecurrent.com/trials/the-effects-of-scapulohumeral-rehabilitation-on-scapula-kinematics-and-upper-extremity-functionality-in-individuals-with-66769https://curecurrent.com/trials/gait-re-education-program-in-subjects-with-parkinson-s-disease-66770https://curecurrent.com/trials/hift-training-in-people-with-parkinson-s-disease-66771https://curecurrent.com/trials/comparing-antipsychotic-medications-in-lbd-over-time-66772https://curecurrent.com/trials/parkinson-s-disease-progression-study-66773https://curecurrent.com/trials/prolactin-inflammation-and-parkinson-s-severity-66774https://curecurrent.com/trials/dbs-of-the-mlr-for-gait-and-balance-disorders-in-pd-patients-66775https://curecurrent.com/trials/a-double-blind-study-to-evaluate-the-safety-of-glutamic-acid-decarboxylase-gene-transfer-in-parkinson-s-participants-66776https://curecurrent.com/trials/testing-if-pdr-001-can-safely-and-effectively-remove-harmful-brain-protein-in-parkinson-s-disease-66777https://curecurrent.com/trials/the-study-is-being-conducted-to-evaluate-the-safety-and-efficacy-of-xjn010-nasal-spray-in-patients-with-parkinson-s-dise-66778https://curecurrent.com/trials/investigation-of-effects-of-delayed-feedback-on-non-motor-symptoms-in-individuals-with-parkinson-s-disease-66779https://curecurrent.com/trials/abnormal-movements-cerebellum-and-sensorimotor-oculomotor-study-66780https://curecurrent.com/trials/microbiota-intervention-to-change-the-response-of-parkinson-s-disease-66781https://curecurrent.com/trials/evaluation-of-the-personal-kinetigraph-pkg-to-improve-insight-into-parkinson-s-disease-status-66782https://curecurrent.com/trials/clinical-efficacy-and-mechanism-of-tdcs-for-dysphagia-in-pd-66783https://curecurrent.com/trials/innovative-treatments-for-neurogenic-dysphagia-66784https://curecurrent.com/trials/cognitive-affective-and-motor-effects-of-tangotherapy-in-parkinson-s-disease-66785https://curecurrent.com/trials/study-of-clonidine-efficacy-for-the-treatment-of-impulse-control-disorders-in-parkinson-s-disease-66786https://curecurrent.com/trials/examining-the-validity-and-reliability-of-the-dresden-falls-questionnaire-in-patients-with-parkinson-s-diagnosis-living-66787https://curecurrent.com/trials/preparation-and-feasibility-of-exams-for-expected-studies-66788https://curecurrent.com/trials/physical-activity-in-patients-with-parkinson-s-disease-a-disease-modifying-intervention-66789https://curecurrent.com/trials/evaluation-of-remote-dbs-programming-66790https://curecurrent.com/trials/hift-in-people-with-parkinson-s-disease-66791https://curecurrent.com/trials/remote-mental-practice-for-freezing-of-gait-in-parkinson-s-disease-66792https://curecurrent.com/trials/collection-of-digital-parameters-from-parts-of-the-neurological-examination-using-an-eye-tracker-66793https://curecurrent.com/trials/counterfactual-thinking-and-decision-making-in-parkinson-s-disease-66794https://curecurrent.com/trials/discern-advanced-pd-therapy-candidacy-and-evaluation-system-66795https://curecurrent.com/trials/special-drug-use-results-survey-of-duodopa-enteral-solution-in-patients-with-parkinson-s-disease-66796https://curecurrent.com/trials/deciphering-the-mechanisms-of-central-bp-regulation-in-patients-with-pd-associated-with-orthostatic-hypotension-66797https://curecurrent.com/trials/a-study-of-crexont-carbidopa-and-levodopa-extended-release-capsules-in-participants-with-parkinson-s-disease-66798https://curecurrent.com/trials/mhealth-technology-in-people-with-parkinson-s-disease-66799https://curecurrent.com/trials/quality-improvement-and-practice-based-research-in-neurology-using-the-emr-66800https://curecurrent.com/trials/pembrolizumab-epacadostat-vs-pembrolizumab-placebo-in-recurrent-or-progressive-metastatic-urothelial-carcinoma-66801https://curecurrent.com/trials/high-intensity-functional-training-for-individuals-with-neurologic-diagnoses-and-their-care-partners-66802https://curecurrent.com/trials/pembrolizumab-in-combination-with-epacadostat-or-placebo-in-cisplatin-ineligible-urothelial-carcinoma-keynote-672-echo-3-66803https://curecurrent.com/trials/sch-context-aware-freezing-of-gait-mitigation-in-real-world-setting-66804https://curecurrent.com/trials/dynamic-motor-cortical-responses-to-subdural-electrical-stimulation-66805https://curecurrent.com/trials/effect-of-a-vibrating-therapy-ball-on-tremor-and-daily-activities-in-patients-with-different-tremor-syndroms-66806https://curecurrent.com/trials/eeg-measurements-to-capture-dbs-induced-electric-potentials-66807https://curecurrent.com/trials/study-of-amdx-2011p-as-a-retinal-tracer-in-subjects-with-neurodegenerative-diseases-associated-with-amyloidogenic-protei-66808https://curecurrent.com/trials/design-and-analysis-of-the-effectiveness-of-cvre-vs-non-immersive-vr-in-the-rehabilitation-of-parkinson-66809https://curecurrent.com/trials/speech-accessibility-project-66810https://curecurrent.com/trials/opioidergic-and-noradrenergic-systems-in-central-parkisonian-pain-66811https://curecurrent.com/trials/ps128-may-improve-off-duration-on-parkinson-s-disease-66812https://curecurrent.com/trials/top-set-and-parkinson-s-disease-66813https://curecurrent.com/trials/interval-training-and-parkinson-s-disease-66814https://curecurrent.com/trials/ambroxol-as-a-disease-modifying-treatment-in-gba-pd-66815https://curecurrent.com/trials/use-of-a-non-invasive-brainstem-neuromodulation-device-to-improve-neurovascular-status-in-parkinson-s-disease-66816https://curecurrent.com/trials/segwaypd-the-effect-of-sensory-augmented-postural-training-using-segway-on-motor-and-cognitive-function-in-individuals-w-66817https://curecurrent.com/trials/home-based-gait-and-balance-training-in-patients-with-movement-disorders-66818https://curecurrent.com/trials/role-of-pentoxifylline-and-celecoxib-in-parkinsonism-66819https://curecurrent.com/trials/cognitive-training-in-parkinson-s-disease-66820https://curecurrent.com/trials/safety-and-effectiveness-of-intermittent-hypoxia-treatment-in-parkinson-s-disease-66821https://curecurrent.com/trials/enhancing-utility-of-neuropsychological-evaluation-for-earlier-and-effective-diagnosis-of-dementia-in-parkinson-s-diseas-66822https://curecurrent.com/trials/a-study-comparing-propranolol-and-amantadine-for-reducing-tremors-in-people-with-parkinson-s-disease-66823https://curecurrent.com/trials/the-effects-of-fnirs-based-neurofeedback-training-on-balance-and-gait-in-parkinson-s-disease-66824https://curecurrent.com/trials/training-of-nursing-home-professionals-and-quality-of-life-of-residents-with-parkinson-s-disease-66825https://curecurrent.com/trials/adhesion-and-safety-of-rotigexole-compared-to-neupro-66826https://curecurrent.com/trials/open-label-safety-study-of-dipraglurant-adx48621-in-patients-with-parkinson-s-disease-receiving-levodopa-based-therapy-66827https://curecurrent.com/trials/steps-against-the-burden-of-parkinson-s-disease-telaviv-bologna-66828https://curecurrent.com/trials/quantitation-of-glymphatic-functioning-in-sleep-and-meditative-states-66829https://curecurrent.com/trials/dipraglurant-adx48621-for-the-treatment-of-patients-with-parkinson-s-disease-receiving-levodopa-based-therapy-66830https://curecurrent.com/trials/quantification-tools-for-a-novel-tau-pet-marker-in-a-rare-neurological-disease-18f-pi-2620-in-progressive-supranuclear-p-66831https://curecurrent.com/trials/meridian-activation-remedy-system-for-parkinson-s-disease-66832https://curecurrent.com/trials/study-on-practical-experiences-of-treatment-with-foslevodopa-foscarbidopa-in-advanced-parkinson-s-disease-66833https://curecurrent.com/trials/gait-and-balance-impairment-in-rare-and-very-rare-neurological-diseases-66834https://curecurrent.com/trials/evaluation-of-gm101-injection-in-patients-with-parkinson-s-disease-66835https://curecurrent.com/trials/a-trial-to-evaluate-the-safety-tolerability-and-preliminary-efficacy-of-ncr201-in-the-treatment-of-subjects-with-parkins-66836https://curecurrent.com/trials/micro-ribonucleic-acid-mirna-expression-and-inflammatory-factors-in-patients-with-parkinson-s-and-periodontal-disease-66837https://curecurrent.com/trials/empower-pd-feasibility-of-an-interdisciplinary-clinic-for-people-with-parkinson-s-disease-66838https://curecurrent.com/trials/transcutaneous-vibro-acoustic-therapy-in-parkinson-disease-66839https://curecurrent.com/trials/effect-of-vitamin-d3-on-brain-waves-in-male-parkinson-s-patients-with-low-vitamin-d-a-qeeg-study-66840https://curecurrent.com/trials/evaluation-of-functional-and-biochemical-effectiveness-of-a-strength-training-protocol-in-parkinson-s-disease-66841https://curecurrent.com/trials/randomized-placebo-controlled-trial-of-n-acetylcysteine-in-parkinson-s-disease-patients-a-pilot-study-66842https://curecurrent.com/trials/integration-of-augmented-visual-feedback-in-action-observation-and-motor-imagery-therapy-for-parkinson-s-disease-66843https://curecurrent.com/trials/effect-of-vitamin-d3-supplementation-on-cardiac-autonomic-nerve-function-in-male-parkinson-s-disease-patients-with-hypov-66844https://curecurrent.com/trials/long-term-longitudinal-imaging-of-presynaptic-terminals-in-pd-66845https://curecurrent.com/trials/fdopa-pet-and-nutritional-support-in-parkinson-s-disease-66846https://curecurrent.com/trials/incmga00012-in-patients-with-previously-treated-unresectable-or-metastatic-adenosquamous-pancreatic-or-ampullary-cancer-66847https://curecurrent.com/trials/fixed-dose-trial-in-early-parkinson-s-disease-pd-66848https://curecurrent.com/trials/turn-it-fog-improving-turning-and-freezing-of-gait-in-people-with-pd-66849https://curecurrent.com/trials/prospective-study-for-neuromelanin-image-analysis-66850https://curecurrent.com/trials/the-effect-of-compensation-strategies-on-gait-impairment-in-parkinson-s-disease-66851https://curecurrent.com/trials/a-clinical-study-of-the-safety-and-efficacy-of-chemogenetics-therapy-in-the-treatment-of-parkinson-s-disease-66852https://curecurrent.com/trials/the-stereo-dbs-study-7-tesla-mri-brain-network-analysis-for-deep-brain-stimulation-66853https://curecurrent.com/trials/proseek-a-phase-2-study-in-early-parkinson-s-disease-patients-evaluating-the-safety-and-efficacy-of-abl-tyrosine-kinase-66854https://curecurrent.com/trials/effect-of-rasagiline-on-balance-in-parkinson-s-disease-as-measured-by-computerized-posturography-66855https://curecurrent.com/trials/personalized-stimulation-loop-for-neurorehabilitation-in-parkinson-a-proof-of-principle-study-66856https://curecurrent.com/trials/a-novel-measurement-concept-to-objectively-quantify-severity-of-vocal-and-speech-related-symptoms-associated-with-parkin-66857https://curecurrent.com/trials/oscillatory-activity-in-basal-ganglia-circuits-during-normal-and-pathological-movement-66858https://curecurrent.com/trials/evaluation-of-the-effectiveness-of-the-parkinson-specialized-teams-intervention-66859https://curecurrent.com/trials/interdisciplinary-intersectoral-telemedicine-evaluation-coordination-treatment-in-rhinemain-parkinson-s-network-66860https://curecurrent.com/trials/adaptive-neurostimulation-to-restore-sleep-in-parkinson-s-disease-aim-2-66861https://curecurrent.com/trials/perception-of-affordances-and-obstacle-crossing-in-people-with-parkinson-s-disease-and-healthy-adults-66862https://curecurrent.com/trials/brain-mechanisms-of-social-perception-in-parkinson-s-disease-66863https://curecurrent.com/trials/insulin-resistance-in-multiple-system-atrophy-66864https://curecurrent.com/trials/acupuncture-and-moxibustion-for-motor-symptoms-in-early-parkinson-s-disease-66865https://curecurrent.com/trials/a-study-of-pembrolizumab-mk-3475-for-first-line-treatment-of-recurrent-or-metastatic-squamous-cell-cancer-of-the-head-an-66866https://curecurrent.com/trials/vigor-and-the-ldr-in-parkinson-disease-66867https://curecurrent.com/trials/robotic-apparel-to-prevent-freezing-of-gait-in-parkinson-disease-66868https://curecurrent.com/trials/a-study-of-pembrolizumab-in-combination-with-cisplatin-and-pemetrexed-in-advanced-malignant-pleural-mesothelioma-mpm-mk-66869https://curecurrent.com/trials/steps-against-the-burden-of-parkinson-s-disease-66870https://curecurrent.com/trials/effect-of-metronome-based-structured-rhythmic-exercise-program-on-freezing-and-gait-parameters-in-parkinson-disease-66871https://curecurrent.com/trials/lighting-intervention-to-improve-sleep-66872https://curecurrent.com/trials/the-effect-of-a-lighting-intervention-on-sleep-in-parkinson-disease-66873https://curecurrent.com/trials/apraxia-in-parkinson-s-disease-patients-with-deep-brain-stimulation-66874https://curecurrent.com/trials/altropane-dose-for-imaging-patients-with-suspected-parkinson-s-disease-66875https://curecurrent.com/trials/smart-pd-evaluating-the-impact-of-smartphone-based-wearable-technology-on-motor-symptoms-and-quality-of-life-in-people-w-66876https://curecurrent.com/trials/mediterranean-diet-effects-on-parkinson-s-disease-66877https://curecurrent.com/trials/steps-against-the-burden-of-parkinson-s-disease-rct-kiel-66878https://curecurrent.com/trials/effect-of-metformin-as-add-on-therapy-in-levodopa-treated-parkinson-s-disease-patients-66879https://curecurrent.com/trials/brain-activity-during-complex-walking-in-people-with-atypical-parkinsonian-syndromes-66880https://curecurrent.com/trials/n-dose-a-dose-optimization-trial-of-nicotinamide-riboside-in-parkinson-s-disease-66881https://curecurrent.com/trials/effect-of-ai-chatbot-assisted-versus-traditional-case-based-learning-on-clinical-reasoning-in-occupational-therapy-stude-66882https://curecurrent.com/trials/prevent-cognitive-decline-in-gba-associated-parkinson-s-disease-66883https://curecurrent.com/trials/adaptive-dbs-algorithm-for-personalized-therapy-in-parkinson-s-disease-66884https://curecurrent.com/trials/the-effects-of-24-weeks-community-based-brisk-walking-in-people-with-parkinson-s-disease-66885https://curecurrent.com/trials/stem-pd-open-label-extension-ole-66886https://curecurrent.com/trials/vim-ptt-mrgfus-for-pd-66887https://curecurrent.com/trials/sing-for-your-saunter-66888https://curecurrent.com/trials/misfolded-proteins-in-the-skin-of-people-with-parkinson-s-disease-and-other-parkinsonism-66889https://curecurrent.com/trials/the-safety-feasibility-and-efficacy-of-nouvneu001-for-parkinson-s-disease-66890https://curecurrent.com/trials/telerehabilitation-dual-task-training-for-parkinson-s-a-multidimensional-evaluation-66891https://curecurrent.com/trials/feasibility-of-a-behavioural-activation-protocol-to-support-people-with-parkinson-s-enhanced-by-vr-66892https://curecurrent.com/trials/fecal-microbiota-transplantation-via-oral-capsule-for-treating-refractory-constipation-in-parkinson-s-disease-66893https://curecurrent.com/trials/barre-exercise-in-parkinson-s-66894https://curecurrent.com/trials/tapping-test-and-the-archimedean-spiral-for-the-differential-diagnosis-of-tremor-machine-learning-approach-66895https://curecurrent.com/trials/fecal-microbiotatransplant-for-the-treatment-of-parkinson-s-disease-66896https://curecurrent.com/trials/feasibility-and-effects-of-a-pickleball-program-for-people-with-parkinson-disease-66897https://curecurrent.com/trials/exercise-adherence-and-optimal-nutrition-post-rehabilitation-among-people-with-parkinson-s-disease-66898https://curecurrent.com/trials/efficacy-and-safety-of-entacapone-combined-with-madopar-in-the-treatment-of-early-parkinson-s-disease-an-observational-m-66899https://curecurrent.com/trials/btrx-246040-study-in-participants-with-parkinson-s-disease-with-motor-fluctuations-66900https://curecurrent.com/trials/clinical-investigation-of-nms-assist-66901https://curecurrent.com/trials/the-effect-of-spinal-mobilization-on-respiratory-parameters-in-parkinson-s-disease-patients-66902https://curecurrent.com/trials/a-post-marketing-surveillance-study-of-equfina-tablet-50-milligram-mg-66903https://curecurrent.com/trials/infusion-of-apomorphine-long-term-safety-study-66904https://curecurrent.com/trials/a-study-of-pembrolizumab-mk-3475-plus-carboplatin-and-paclitaxel-as-first-line-treatment-of-recurrent-metastatic-head-an-66905https://curecurrent.com/trials/effects-of-biofeedback-exercises-on-severity-of-dysphagia-in-parkinson-s-clients-66906https://curecurrent.com/trials/pragmatic-cyclical-lower-extremity-exercise-trial-for-parkinson-s-disease-66907https://curecurrent.com/trials/moving-mindfully-for-freezing-of-gait-66908https://curecurrent.com/trials/the-efficacy-and-safety-of-precision-repetitive-transcranial-magnetic-stimulation-in-alleviating-motor-symptom-in-parkin-66909https://curecurrent.com/trials/impact-of-frequency-specific-subthalamic-nucleus-subregion-stimulation-on-inhibitory-control-in-parkinson-s-disease-66910https://curecurrent.com/trials/turning-pattern-of-different-body-segments-during-turns-and-turning-performance-66911https://curecurrent.com/trials/cognitive-motor-training-in-parkinson-disease-66912https://curecurrent.com/trials/evaluation-of-neurocognitive-changes-in-parkinson-s-disease-after-low-frequency-burst-stimulation-66913https://curecurrent.com/trials/mobile-parkinson-observatory-for-worldwide-evidence-based-research-mpower-66914https://curecurrent.com/trials/curative-effect-and-mechanism-of-transcutaneous-auricular-vagus-nerve-stimulation-on-sleep-disorders-of-pd-66915https://curecurrent.com/trials/characterising-physiological-resilience-in-people-with-parkinson-s-disease-66916https://curecurrent.com/trials/modulation-of-cognitive-control-via-transcranial-continuous-electrical-stimulation-of-additional-motor-areas-in-parkinso-66917https://curecurrent.com/trials/speech-linguistic-and-acoustic-markers-in-parkinson-s-disease-66918https://curecurrent.com/trials/integrating-ai-in-postural-rehabilitation-for-parkinson-s-disease-66919https://curecurrent.com/trials/study-of-safety-and-efficacy-of-pembrolizumab-and-chemotherapy-in-participants-with-newly-diagnosed-classical-hodgkin-ly-66920https://curecurrent.com/trials/a-pilot-study-to-explore-the-role-of-gut-flora-in-parkinson-s-disease-66921https://curecurrent.com/trials/vc-vs-for-apathy-in-pd-66922https://curecurrent.com/trials/a-pilot-comparative-bioavailability-study-of-levodopa-administered-via-levodopa-cyclops-relative-to-inbrija-66923https://curecurrent.com/trials/mechanism-and-application-of-dbs-in-the-treatment-of-pd-66924https://curecurrent.com/trials/amped-pd-amplifying-physical-activity-through-music-in-parkinson-disease-66925https://curecurrent.com/trials/a-long-term-safety-study-of-nd0612-administered-as-a-continuous-sc-infusion-in-advanced-parkinson-s-disease-66926https://curecurrent.com/trials/combined-stn-and-nbm-deep-brain-stimulation-for-mild-cognitive-impairment-in-parkinson-s-disease-66927https://curecurrent.com/trials/nopark-open-label-extension-study-66928https://curecurrent.com/trials/study-of-favezelimab-mk-4280-as-monotherapy-and-in-combination-with-pembrolizumab-mk-3475-with-or-without-chemotherapy-o-66929https://curecurrent.com/trials/monocentric-prospective-study-to-assess-the-pharmacokinetic-profile-of-continuous-and-diurnal-subcutaneous-apomorphine-i-66930https://curecurrent.com/trials/mass-balance-recovery-and-metabolite-identification-of-carbon-14-bia-28-6156-66931https://curecurrent.com/trials/burst-type-deep-brain-stimulation-of-the-subthalamic-nucleus-in-parkinson-s-disease-66932https://curecurrent.com/trials/evaluation-of-impaired-mobility-in-chronic-illness-constitution-of-a-cohort-66933https://curecurrent.com/trials/pembrolizumab-mk-3475-as-first-line-therapy-for-advanced-merkel-cell-carcinoma-mk-3475-913-66934https://curecurrent.com/trials/molecular-mediators-of-physical-exercise-and-carnosine-induced-effects-in-patients-with-preclinical-and-early-stage-neur-66935https://curecurrent.com/trials/spinal-cord-stimulation-therapy-for-parkinson-s-disease-patients-with-gait-problems-66936https://curecurrent.com/trials/the-effects-of-ballet-based-exercise-training-on-respiratory-functions-balance-cognitive-functions-peripheral-muscle-str-66937https://curecurrent.com/trials/tele-rehabilitation-intervention-in-community-based-healthcare-for-patients-with-parkinson-s-disease-dheal-com-pd-66938https://curecurrent.com/trials/mapping-levodopa-effects-on-cortico-basal-ganglia-circuit-function-in-parkinson-s-disease-66939https://curecurrent.com/trials/mid-frontal-delta-theta-and-cognitive-control-66940https://curecurrent.com/trials/investigating-central-neurophysiologic-correlates-of-non-motor-symptoms-of-parkinson-s-disease-66941https://curecurrent.com/trials/evaluating-the-effect-of-mirtazapine-on-anxiety-in-parkinson-s-disease-patients-66942https://curecurrent.com/trials/photobiomodulation-and-parkinson-66943https://curecurrent.com/trials/efficacy-safety-and-tolerability-study-of-nd0612-vs-oral-immediate-release-levodopa-carbidopa-ir-ld-cd-in-subjects-with-66944https://curecurrent.com/trials/wearable-devices-assist-in-the-detection-screening-and-management-of-major-diseases-in-middle-aged-and-elderly-populatio-66945https://curecurrent.com/trials/parkinson-and-the-males-body-composition-66946https://curecurrent.com/trials/chest-mobility-strength-physical-activity-and-quality-of-life-in-parkinson-s-patients-with-post-covid-19-66947https://curecurrent.com/trials/physical-activity-on-neuroinflammation-in-parkinson-s-disease-66948https://curecurrent.com/trials/a-general-anesthesia-regimen-for-dbs-surgery-in-patients-with-pd-66949https://curecurrent.com/trials/impact-of-switching-to-continuous-release-dopamine-agonists-66950https://curecurrent.com/trials/relative-bioavailability-study-of-hrg2010-in-healthy-subjects-66951https://curecurrent.com/trials/mobility-in-atypical-parkinsonism-a-trial-of-physiotherapy-66952https://curecurrent.com/trials/optimizing-bci-fit-brain-computer-interface-functional-implementation-toolkit-66953https://curecurrent.com/trials/prevalence-and-characteristics-of-restless-leg-syndrome-in-thai-patients-with-parkinson-s-disease-66954https://curecurrent.com/trials/internet-delivered-cognitive-rehabilitation-for-mild-cognitive-impairments-66955https://curecurrent.com/trials/step-up-to-pd-a-community-based-walking-program-for-people-with-parkinson-s-disease-66956https://curecurrent.com/trials/effects-of-amazonian-dance-on-motor-and-non-motor-symptoms-of-people-with-parkinson-s-study-protocol-66957https://curecurrent.com/trials/stem-parkinson-s-disease-66958https://curecurrent.com/trials/expiratory-muscle-training-and-trunk-flexion-in-parkinson-s-disease-66959https://curecurrent.com/trials/sharpen-parkinson-s-disease-dementia-66960https://curecurrent.com/trials/effects-of-bilateral-gpi-dbs-on-freezing-of-gait-in-pd-66961https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-gt-02287-in-parkinson-s-disease-66962https://curecurrent.com/trials/a-pilot-study-of-a-non-invasive-neuromodulation-device-for-treatment-of-parkinson-s-disease-66963https://curecurrent.com/trials/early-cogn-3-smart-digital-solutions-for-early-treatment-of-cognitive-disability-a-neuropsychological-neurophysiological-66964https://curecurrent.com/trials/global-registry-exablate-neuro-mr-guided-focused-ultrasound-mrgfus-of-neurological-disorders-66965https://curecurrent.com/trials/effect-of-trunk-flexion-on-airway-defense-in-parkinson-s-disease-66966https://curecurrent.com/trials/parkinsonism-related-oscillations-in-the-cortico-basal-ganglia-thalamic-network-during-movement-beyond-the-frequency-ran-66967https://curecurrent.com/trials/the-efficacy-and-mechanism-of-sma-m1-repetitive-transcranial-magnetic-stimulation-on-freezing-of-gait-in-pd-66968https://curecurrent.com/trials/exablate-transcranial-mrgfus-for-the-management-of-treatment-refractory-movement-disorders-66969https://curecurrent.com/trials/ambroxol-to-slow-progression-in-parkinson-disease-66970https://curecurrent.com/trials/pre-biotics-and-probiotics-for-constipation-in-parkinson-s-disease-66971https://curecurrent.com/trials/exablate-transcranial-mrgfus-for-unilateral-pallidotomy-for-the-treatment-of-parkinson-s-disease-66972https://curecurrent.com/trials/self-care-in-parkinson-s-disease-a-study-on-patients-and-caregivers-self-care-in-the-patient-caregiver-dyad-with-parkins-66973https://curecurrent.com/trials/clinical-trial-of-vildagliptin-in-early-parkinson-s-disease-66974https://curecurrent.com/trials/ai-enhanced-optimization-of-acute-levodopa-challenge-test-66975https://curecurrent.com/trials/effect-of-fecal-microbiota-transfer-on-progression-of-parkinson-disease-66976https://curecurrent.com/trials/effects-of-motor-imagery-and-action-observation-on-upper-limb-motor-chances-and-cognitive-chances-in-parkinson-s-disease-66977https://curecurrent.com/trials/visualization-of-the-stn-and-gpi-for-dbs-66978https://curecurrent.com/trials/one-year-effect-on-levodopa-equivalent-daily-dose-of-thalamic-vim-nucleus-stimulation-compared-to-subthalamic-nucleus-st-66979https://curecurrent.com/trials/sleep-hygiene-intervention-on-sleep-quality-improvement-in-elders-with-parkinson-s-disease-66980https://curecurrent.com/trials/stepwise-parkinson-a-smartphone-based-exercise-solution-for-patients-with-parkinson-s-disease-66981https://curecurrent.com/trials/low-load-resistance-training-with-blood-flow-restriction-in-people-with-parkinson-s-disease-66982https://curecurrent.com/trials/tus-to-disrupt-pathological-oscillations-66983https://curecurrent.com/trials/the-efficacy-and-safety-of-transcranial-temporal-interference-stimulation-ttis-targeting-the-right-globus-pallidus-inter-66984https://curecurrent.com/trials/the-brainmap-dbs-study-brain-network-analysis-using-7-tesla-mri-and-magnetoencephalography-for-deep-brain-stimulation-66985https://curecurrent.com/trials/safety-of-cultured-allogeneic-adult-umbilical-cord-derived-mesenchymal-stem-cell-exosomes-for-parkinson-s-disease-66986https://curecurrent.com/trials/research-on-novel-biomarkers-for-early-diagnosis-of-parkinson-s-disease-an-observational-multicenter-non-randomized-cont-66987https://curecurrent.com/trials/mindfulness-enhanced-dual-task-training-in-pd-mci-66988https://curecurrent.com/trials/lrrk2-gba-and-other-genetic-biomarkers-in-eastern-european-ashkenazi-jews-with-and-without-parkinson-s-disease-66989https://curecurrent.com/trials/retinal-biomarkers-in-parkinson-s-disease-66990https://curecurrent.com/trials/parkinson-disease-and-exercise-snacks-66991https://curecurrent.com/trials/seated-tai-chi-improves-dynamic-finger-pointing-task-and-sitting-balance-control-in-subjects-with-parkinson-s-disease-66992https://curecurrent.com/trials/psychological-effects-of-levodopa-in-parkinson-s-disease-66993https://curecurrent.com/trials/international-validation-of-two-non-motor-scales-in-pd-nfs-and-spark-66994https://curecurrent.com/trials/non-motor-symptoms-and-brain-dopamine-transporter-binding-66995https://curecurrent.com/trials/non-drug-treatment-study-in-parkinson-s-disease-patients-and-healthy-volunteers-to-collect-biological-samples-in-order-t-66996https://curecurrent.com/trials/preventing-levodopa-induced-dyskinesia-in-parkinson-s-disease-with-hmg-coa-reductase-inhibitors-66997https://curecurrent.com/trials/effect-of-synbiotic-as-an-adjuvant-therapy-in-the-treatment-of-parkinson-s-disease-66998https://curecurrent.com/trials/use-of-a-tongue-strength-training-device-and-its-relationship-with-speech-in-patients-with-parkinson-s-disease-66999https://curecurrent.com/trials/effects-and-mechanisms-of-ras-training-on-upper-limb-movements-in-pd-patients-67000https://curecurrent.com/trials/home-based-monitoring-in-parkinson-s-disease-67001